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Abstract and Keywords 
 The chemistry of cyclobutane-1,1-diester has been investigated with aldehydes 
and alkyne reaction partners independently of each other. Under Yb(OTf)3 catalysis 
donor-acceptor cyclobutanes undergo a formal [4+2] cycloaddition with aldehydes to 
generate tetrahydropyrans exclusively in a cis disposition. Activated aldehydes were 
generally well tolerated giving tetrahydropyrans in moderate to good yields (51 - 89%) 
whereas less reactive congeners gave lower yields (51 - 72%).  
 All carbon reaction partners were used in BF3·OEt2 mediated conditions to afford 
an unexpected 2,3-dihydrooxepine product resulting from alkynyl addition and 
rearrangement. Aryl acetylenes were compatible with the reaction conditions and 
moderate yields were obtained (31 - 53%). When a silyl ether protected aryl acetylene 
was deployed the expected formal [4+2] cycloadduct is observed. 
 The application of a water soluble Co(nmp)2 catalyst was used in the progress 
towards the polyketides natural product biselide A. Key reactions for the formation of a 
single diastereomer of an advanced stage intermediate included: Evans’ asymmetric aldol 
and a Prasad reduction to form a 1,3-syn diol exclusively which cyclized with Co(nmp)2 
in high yield (93%). A tethering strategy will be used for the formation of the 
macrocyclic portion of the natural product. 
 
Key words: dipolar cycloaddition, donor-acceptor cyclobutanes, alkyne, aldehydes, 
Lewis acid, total synthesis, natural products, tetrahydrofurans, oxidative cyclization, 
biselide A 
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Chapter 1 - Reactions of Cyclobutane-1,1-diesters with Aldehydes and Alkynes 
 This chapter describes two independent intermolecular reactions of donor-
acceptor cyclobutanes with aldehydes (Section 1.2.1) followed by terminal alkynes 
(Section 1.2.2). An overview of the field of annulation reactions with donor-acceptor 
cyclopropanes and how this structure’s reactivity was expanded to the cyclobutane 
homologue is discussed. An in depth examination of the current literature of donor-
acceptor cyclobutanes will be presented. The work presented in Section 1.2.1 of this 
chapter was performed in collaboration with Mr. Andrew Stevens and Mr. Mahmoud 
Moustafa, PhD, while Section 1.2.2 was done entirely by me. Portions of this work have 
been published and are reproduced with permission from the American Chemical Society 
and Thieme. Both the aldehyde
1
 and alkyne
2
 works have been published in peer-reviewed 
journals. 
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1.1 - Introduction  
1.1.1 - General introduction to strained ring systems and cyclobutanes 
 The application of small ring systems for the construction of highly functionalized 
molecules has recently risen to the forefront of synthetic chemistry.
3
 Cyclopropanes (1-1) 
and cyclobutanes (1-2) are highly strained molecules which can be easily cleaved under 
appropriate conditions. In contrast, the larger ring systems (cyclopentanes (1-3) and 
cyclohexenes (1-4)) have substantially less strain energy and have not been applied for 
the same type of chemical transformations as the three and four-membered molecules 
(Figure 1.1).
4
 
 
 
Figure 1.1 Strain energies of small carbocycles 
 
 The cyclobutane ring has carbon-carbon bond angles which are significantly 
smaller than the typically 109.5° for the standard tetrahedral geometry. This decreased 
bond angle allows much of the fascinating reactivity observed for these systems.
5
 Figure 
1.2 shows a representation of this puckering with the C-C-C bond angle being slightly 
less than 90° to lessen the ring strain.
5
 These unique properties of cyclopropanes and 
cyclobutanes have developed them into particularly useful synthons in a wide variety of 
reactions. 
 
3 
 
 
Figure 1.2 Pictorial representation of the puckering of a cyclobutane 
 
1.1.2 Donor-acceptor cyclopropanes 
 Donor-acceptor (DA) cyclopropanes have warranted a considerable amount of 
attention from synthetic chemists.
6
 The chemistry of cyclopropanes can allow for 
differing reactivity depending on the substitution pattern (Figure 1.3). With an appended 
electron-donating group, cyclopropane can interact as a nucleophile (eq 1), whereas when 
bearing an electron-accepting substituent, the electrophilic cyclopropane can be opened 
by a nucleophile (eq 2) in a homo-Michael manner. A third and more useful method of 
activating cyclopropane is using electron-donating and withdrawing substituents vicinal 
to each other. If a Lewis acid is present, bond cleavage can generate a zwitterionic 
intermediate which, when intercepted with an appropriate dipole, can generate complex 
carbo- or heterocycles (eq 3).
6d
  
 
 
4 
 
 
Figure 1.3 Potential modes of activation of cyclopropanes 
 
 The Pagenkopf group has been interested in the application of DA-cyclopropanes 
and their ability to generate highly functionalized heterocycles. For instance, in 2003, a 
methodology was developed for the formation of pyrroles.
7
 Donor-acceptor (DA) 
cyclopropane 1-5 was treated with TMSOTf in the presence of a nitrile (1-6), the reaction 
can generate tetrasubstituted pyrroles (1-7). Additionally, if a [4.1.0]-bicyclic 
cyclopropane is used the reaction can generate indoles after oxidation. This methodology 
has been subsequently applied to the synthesis of two indole alkaloids, goniomitine (1-8)
8
 
and quebrachamine (1-9)
9
 (Scheme 1.1). 
5 
 
 
Scheme 1.1 Synthesis of pyrroles from DA-cyclopropanes and application in total 
synthesis 
 
 Several other reaction partners have been subject to investigation by the 
Pagenkopf group. This general idea has been applied to indoles,
10
 allylsilanes,
11
 and 
pyridines or quinolines.
12
 Additionally, several other groups have utilized dipolar 
cycloadditions of cyclopropanes in methodology studies
13
 as well as for the total 
synthesis of complex natural products.
14
 
 
1.1.3 Intermolecular annulations of cyclobutanes 
 Cyclobutanes have been used in various methodology studies,
15
 including ring 
expansion reactions,
16
 metal-catalyzed activation of carbon-carbon bonds,
17
 and Baeyer-
Villiger oxidations.
18
 Considering the rich history of cyclobutane chemistry, DA-
cyclobutanes have had considerably less attention from synthetic chemists. Additionally, 
as their ring strain energies are comparable to the cyclopropane homologue, DA-
cyclobutanes should be amenable to similar reactions.  
6 
 
 The synthesis of DA-cyclobutanes dates back to 1986.
19
 Roberts reported that 
methylene malonate 1-10, when treated with a stoichiometric amount of ZnBr2 and enol 
ether 1-11, provided cyclobutane 1-12 in good yield (Scheme 1.2).  
 
 
Scheme 1.2 Roberts' synthesis of DA-cyclobutanes 
 
 Although the method developed by Roberts provided a facile route to these four-
membered rings, however their application in cycloadditions was not reported until 
several years later. In 1991 however, the first application of a slightly different DA-
cyclobutane was reported for dipolar cycloadditions.
20
 It was proposed that these 
compounds could undergo a bond cleavage in the presence of a Lewis acid to generate a 
potentially useful 1,4-dipole equivalent. Saigo reported that amino activated cyclobutane 
mono-ester 1-13 reacted with aldehydes or ketones when treated with TiCl4 to furnish 
tetrahydropyrans 1-14, albeit in moderate yields and poor diastereoselectivity (Scheme 
1.3). 
 
 
 
7 
 
 
Scheme 1.3 Seminal DA-cyclobutane cycloaddition to form tetrahydropyrans by Saigo 
 
 Following this proof of concept work by Saigo, Matsuo deployed cyclobutanones 
as dipolarophiles for annulation reactions in 2008 with aldehydes and ketones (Scheme 
1.4).
21
 Matsuo reported that under Lewis acid mediated conditions the reaction between 
cyclobutanone 1-15 and aldehydes or ketones 1-16 proceeded to provide 
tetrahydropyrans 1-17 in moderate to good yields.
21
 
 
 
Scheme 1.4 Matsuo’s cycloaddition of cyclobutanones with aldehydes/ketones 
  
8 
 
 Subsequent dipoles employed with cyclobutanone 1-15 included allylsilanes,
22
 
silyl enol ethers
23
 and alkenes
24
 to afford three different cyclohexanone derivatives in 
moderate to good yields, 1-18, 1-19, and 1-20 respectively (Scheme 1.5). 
 
 
Scheme 1.5 Dipole scope for annulation with cyclobutanone 
 
 Matsuo was also able to generate higher complexity structures and the formation 
of an asymmetric variant using aldehydes.
25
 Cyclobutanones were also elaborated into 
two natural products. In one account, Matsuo used imine 1-21 in the presence of a TiCl4 
with cyclobutanone 1-22 in an efficient reaction to generate pyridone 1-23 which was 
further manipulated into the natural product bremazocine 1-24 (Scheme 1.6).
26
 
9 
 
 
Scheme 1.6 Matsuo’s total synthesis of (±)-bremazocine 
 
 Matsuo described the application of protected indoles (1-25) with cyclobutanones 
1-15 under Lewis acid catalyzed conditions to generate various functionalized carbazoles 
(1-26) (Scheme 1.7).
27
 
 
 
Scheme 1.7 Construction of carbazoles 
 
 After methodology development, the total synthesis of aspidospermidine was 
accomplished from a more complex cyclobutanone (Scheme 1.8).
27
 Elaboration of 
eneamine 1-27 provided access to cyclobutanone 1-28 which underwent an 
intramolecular [4+2] cycloaddition to form indoline 1-29 which, in 3 steps, was 
converted into (±)-aspidospermidine 1-30.  
10 
 
 
Scheme 1.8 Cycloaddition for the synthesis of aspidospermidine 
 
 A Lewis acid switch was required for the intramolecular reaction to proceed and 
TMSOTf was used. In the presence of the Lewis acid, iminium ion 1-31 is formed which 
can be subsequently attacked by the C-3 of the indole portion. Ring closure results from 
the silyl enol ether portion which undergoes a substitution reaction at C-2 of the 
indoline.
27
 
 In 2009 cyclobutane-1,1-diesters were observed to undergo formal [4+2] 
cycloaddition with aldehydes in excellent yields and selectivity. These compounds 
undergo bond polymerization similar to the cyclobutanones; however the presence of a 
diester moiety allows for higher stabilization of the malonyl anion generated upon ring 
opening. Seminal work reported on the application of these types of DA-cyclobutanes 
was presented by the Johnson
28
 and the Christie and Pritchard research groups
29
 with 
both reporting the application of aldehyde dipoles to generate tetrahydropyrans. 
 The work of Johnson used aryl or vinyl activated cyclobutane diesters (1-32) 
under Sc(OTf)3 catalyzed conditions with either aryl or aliphatic aldehydes (1-33) to form 
11 
 
tetrahydropyrans (1-34) with complete diastereoselectivity for the cis-isomer.
28
 It is 
interesting to note, as it will become important in Section 1.2, that in the presence of the 
less reactive aliphatic aldehydes an alternative catalyst was need. An aluminum 
triflimide, as opposed to Sc(OTf)3, was used for aliphatic aldehydes (Scheme 1.9).
28
 
 
 
Scheme 1.9 Johnson’s formal [4+2] dipolar cycloaddition 
 
 Christie and Pritchard’s dipolarophile was activated in a Nicholas-type manner by 
means of a cobalt alkyne complex. Consistently high yields and diastereoselectivity were 
obtained under Sc(OTf)3 catalyzed reaction conditions with DA-cyclobutane 1-35 for the 
corresponding tetrahydropyran 1-36. As with Johnson’s work, the cis-diastereomer was 
obtained exclusively in all cases with the exception of smaller aldehydes such as 
acetaldehyde and ethyl glyoxylate (Scheme 1.10).
29
 
 
  
Scheme 1.10 Christie and Pritchard’s Nicholas-activated DA-cyclobutanes 
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 The Pagenkopf group became interested in alkoxy-activated cyclobutane diesters 
as their were similar in the alkoxy activated DA-cyclopropanes for the synthesis of 
pyrroles. Initial forays of these dipolarophiles began with aldehydes
1 
and imines,
30
 with 
subsequent reports extended to acetylenes
2
 and nitrones (Scheme 1.11).
31
 Alkoxy-
activated cyclobutane 1-37 was subjected to various reaction conditions with the 
aforementioned dipoles to give tetrahydropyrans 1-38, tetrahydropyridines 1-39, 
dihydrooxepines 1-40, and oxazepines 1-41, respectively.  
 
 
Scheme 1.11 Pagenkopf’s application of alkoxy-activated DA-cyclobutanes 
 
 A discussion and further details on the development and application of the 
reactions with aldehydes and terminal acetylenes will be presented in the following 
section. 
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1.2 - Results and discussion 
1.2.1 - Formal [4+2] cycloaddition of donor-acceptor cyclobutanes with aldehydes 
 Alkoxy-activated cyclobutanediesters were investigated as compatible 
dipolarophiles in the reaction with aromatic aldehydes. The requisite DA-cyclobutanes 
were synthesized through a two-step procedure which began with Knoevenagel 
condensation of malonate 1-42 with paraformaldehyde to generate the highly reactive 
methylidene malonate 1-43. The malonate (1-43) was then treated with dihydrofuran 
under Zn(OTf)2 catalyzed conditions to afford the desired DA-cyclobutane 1-37 (Scheme 
1.12). In 2009, after attempting Roberts’ ZnBr2 mediated conditions we reported the 
synthesis of DA-cyclobutane 1-37 under Yb(OTf)3 catalysis.
30
 However, it was realized 
that under Zn(OTf)2 catalyzed conditions that DA-cyclobutane 1-37 could be obtained in 
higher yields, as the presence of even trace amounts of Yb(OTf)3 lead to gradual 
decomposition. 
 
 
Scheme 1.12 Representative two-step synthesis of DA-cyclobutane 1-37 
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1.2.1.1 - Optimization of reaction conditions 
 As there had been numerous reports on the successful application of Yb(OTf)3 
with dipoles when DA-cyclopropanes were used,
13
 we opted to begin our investigations 
with this same catalyst. Using benzaldehyde as the dipole, cyclobutanediester 1-37 was 
treated with Yb(OTf)3 under a variety of reaction conditions to afford 1-38a (Table 1.1). 
 
Table 1.1 Reaction optimization 
 
entry
a Yb(OTf)3 
(mol %) 
PhCHO 
(equiv) 
temp 
(°C) 
time 
(min) 
yield 
(%)
b 
1 10 3 -40 120 70 
2 10 3 0 15 84 
3 10 3 20 15 78 
4 10 1.1 0 15 78 
5 10 0.9 0 15 68 
6 2 1.1 0 45 74 
7
c 
0.5 1.1 25 18 h 79 
8
d 
2 1.1 60 2 76 
a
 Reaction conditions: 0.4 mmol of 1-37, CH2Cl2 (2 mL). 
b
 Isolated yield. 
 
c
 No reaction observed at 0 °C. 
d
 Reaction run in a microwave reactor. 
Optimization conducted in collaboration with Andrew C. Stevens. 
 
 In all cases, acetal 1-38a was obtained exclusively as a single diastereomer. The 
reaction gave good yields with all conditions tested. At 10 mol % Yb(OTf)3 the reaction 
proceeded quickly at 0 °C compared to colder temperatures (compare Table 1, entry 1 
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with entries 2). Decreasing catalyst loading gave good yields albeit consumption of 1-37 
was observed after prolonged reaction times (entry 6 and 7). In a microwave reactor, 1-37 
was consumed rapidly (2 min), however with slightly lower yield. For ease of performing 
the reaction, 0 °C with 10 mol % catalyst was chosen for examination of the scope. It 
should also be noted that Sc(OTf)3 was capable of forming the desired product; however 
yields were lower as cyclobutane 1-37 decomposed to uncharacterizable species, 
accelerated by the stronger Lewis acid. 
 
1.2.1.2 - Scope and limitations 
 The reaction scope was quite broad. DA-cyclobutane 1-37 was treated under the 
optimized conditions with a variety of aldehydes ranging from aryl to conjugated to 
heteroaromatic, giving bicyclic acetals 1-38 in high yield and as only the cis 
diastereomers (Table 1.2). Irrespective of the electronic nature of aryl aldehydes, the 
reaction proceeded in good yields. Electron rich (Table 2, entry 2), electron poor (entries 
4 and 5) and halogenated (entry 3) gave the acetal product in good yields as did bulky 
substituents (entry 6). Yields were slightly lower when alkynyl aldehydes were employed 
(entry 7) and when conjugated aryl aldehydes were used, good yields could be obtained 
(entry 8). Heteroaromatic gave acceptable yields (entry 10 and 11), while indole derived 
aldehydes produced the desired product in good yields (entry 12). 
 
 
 
16 
 
Table 1.2 Reaction scope with aldehydes 
 
entry
a
 Ar product 
yield 
(%)
b 
1
c,d 
C6H5 1-38a 78 
2
d 
4-MeO-C6H4 1-38b 80 
3
d 
4-Cl-C6H4 1-38c 89 
4
c 
4-CN-C6H4 1-38d 88 
5
d 
4-NO2-C6H4 1-38e 75 
6
c 
1-naphthyl 1-38f 80 
7
d 
2-ethynyl-phenyl 1-38g 62 
8
d 
cinnamyl 1-38h 87 
9
d 
Allyl 1-38i 51 
10
c 
2-furyl 1-38j 71 
11
d 
2-thiofuryl 1-38k 69 
12
c 
N-tosyl-3-indolyl 1-38l 81 
a
 Reaction conditions: 0.4 mmol of 1-37, aldehyde (1.1 equiv), Yb(OTf)3 (10 mol%), CH2Cl2 (2 mL) at 0 
°C. 
b 
Isolated yield. 
c
 Run by Benjamin Machin. 
d
 Run by Andrew Stevens. 
  
 With success being observed with activated aldehydes, the next target for 
compatible aldehydes was that of aliphatic which tend to be less reactive towards 
cycloadditions (Table 1.3).
1,28
 Although yields were generally lower with aliphatic 
aldehydes, the conditions developed with DA-cyclobutane 1-37 gave the desired products 
1-38 without the need to switch to a stronger Lewis acid as with Johnson’s work.28 As in 
their report, a more aggressive MADNTf2 Lewis acid was needed for cycloaddition to 
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occur with aliphatic aldehydes. Our system was receptive to one Lewis acid for all 
aldehydes tested. 
 
Table 1.3 Formal cycloaddition with aliphatic aldehydes 
 
entry
a 
R product 
yield 
(%)
b 
1
c 
hydrocinnamyl 1-38m 68 
2
c 
1-pentyl 1-38n 56 
3
c 
iPr 1-38o 58 
4
d 
Me 1-38p 51 
5
c 
cyclopropyl 1-38q 72 
a
 Reaction conditions: 0.4 mmol of 1-37, aldehyde (1.1 equiv), Yb(OTf)3 (10 mol%), CH2Cl2 (2 mL) at 0 
°C. 
b
 Isolated yield. 
c
 Run by Andrew Stevens. 
d
 Run by Benjamin Machin.  
 
 A final means to expand the scope of the reaction was to examine alternative DA-
cyclobutanes (Table 1.4). As with previous reactions, the products were isolated as single 
diastereomers. Three different alkoxy-activated DA-cyclobutanes were tested for their 
ability to undergo the dipolar cycloaddition and in all cases moderate to good yields were 
obtained with various electron neutral, donating or withdrawing groups, as well as 
aliphatic and heteroaromatic aldehydes. 
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Table 1.4 Different DA-cyclobutanes in dipolar cycloadditions 
 
cyclobutane product, yield (%)
a 
  
 
 
 
 
a 
Isolated yield. Reactions run by Andrew Stevens (1-43a,b and 1-45a,b) or  
Mahmoud Moustafa (1-47a-e), PhD 
 
1.2.1.3 - Confirmation of stereochemistry 
 Confirmation of stereochemistry of the products was realized by means of nOe 
experiments. The cis-disposition of the acetal proton and that of the proton α to the ethyl 
ester moiety was confirmed by the observation of nOe signals in 2-D
 
NMR studies as 
selective irradiation gave an enhanced single for the corresponding proton on the same 
side of the molecule (Figure 1.4). 
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Figure 1.4 Observed nOe interaction in acetal 1-38a 
 
1.2.1.4 - Summary 
 A new application of alkoxy-activated DA-cyclobutanes has been reported. The 
reaction is catalyzed by the Lewis acid Yb(OTf)3 and in all cases provides a bicyclic 
acetal product exclusively as a single diastereomer.  
 
1.2.2 - Reaction of donor-acceptor cyclobutanes with alkynes 
1.2.2.1 - Previous reactions with alkynes 
 Alkynes have been deployed in a limited number of reports in formal dipolar 
cycloaddition chemistry although the cycloadduct product would provide an all-carbon 
scaffold which generated structural complexity. A handful of reports have served notice 
of the potential application of such substrates. Additionally, the utility of a cycloaddition 
between a DA-cyclopropane and an alkyne could serve as a method for synthesis of 
cyclopentene nucleosides, such as neplanocin A (1-50), abacavir (1-51) and (-)-BCA (1-
52) (Figure 1.5).
32
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Figure 1.5 Cyclopentene nucleosides 
 
 The Yadav group in 2004 was first to show terminal aryl alkynes could undergo 
formal [3+2] cycloadditions with all-carbon dipole equivalents such as DA-
cyclopropanes.
33
 Keto-cyclopropane 1-53 underwent a TiCl4 catalyzed reaction with 
acetylenes to afford cyclopentene 1-54 in moderate to good yields (60 - 85%) favoring 
the cis-diastereomer shown (Scheme 1.13). 
 
 
Scheme 1.13 Yadav’s formal [3+2] dipolar cycloaddition of aryl acetylenes 
 
 Further investigation into the application of aryl acetylenes was reported in 2008 
by Ready.
34
 Upon treatment of DA-cyclopropane 1-5 with Me2AlCl and excess silyl ynol 
ether 1-55 provided α,β-unsaturated cyclopentenones 1-56 in low to good yields (29 – 
82%) after silyl enol ether hydrolysis (Scheme 1.14). 
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Scheme 1.14 Ready’s cyclopentenone synthesis 
 
 Alkynes have also been used in reactions with cyclobutanone with transition 
metal catalysts.
35
 Encouraged by these previous reports on the application of alkynes in 
cycloadditions, we sought to investigate their reactivity towards the formation of 
carbocyclic compounds with alkoxy-activated DA-cyclobutanes. 
 
1.2.2.2 - Initial conditions 
 Initial investigation began by performing the reaction under the standard 
conditions previously established for cycloadditions with heteroatom dipoles. DA-
cyclobutane was chosen for optimization studies as its NMR is easily analyzed in 
cycloaddition products, the synthesis proceeds easily and it is a highly stable starting 
material which can be stored for prolonged time. Additionally, as with our other 
cycloaddition projects, it has been the starting material of choice. Unfortunately, initial 
attempts at a [4+2] cycloaddition led to rapid consumption DA-cyclobutane 1-37 forming 
an unidentified product with no observation of a clean product such as the desired [4+2] 
cycloadduct (1-57). An expansive attempted catalyst optimization was undertaken 
varying all possible variables in hopes of forming the desired cycloadduct 1-57 (Scheme 
1.15). Lewis acids investigated included: Yb(OTf)3, Sc(OTf)3, Zn(OTf)2, ZnBr2, AgOTf, 
MgCl2, MgBr2, InBr3, InCl3, TiCl4, Cu(OTf)2 and GaCl3 with a variety of different 
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solvents at different temperatures and pressure, all giving the same result of rapid 
decomposition of both phenylacetylene and the cyclobutane. To enhance the 
nucleophilicity of the alkyne, 2-ethynyl-4-methoxybenzene was also looked at however, 
the same results were observed. 
 
 
Scheme 1.15 Initial attempts at the cycloaddition 
 
 Several other methods were also tested to give a compound which could be 
cyclized to 1-57 (Scheme 1.16). As the alkynyl proton is acidic, deprotonation followed 
by formation of alkynoate was attempted. Various bases and metal additives gave 
alkylated furan 1-58 in low yield (20 - 40%). Attempts to convert alkylated 
tetrahydrofuran to the fully cyclized cyclohexene 1-57 proved difficult. Electrophilic 
cyclization
36
 was attempted as was a two-step protocol beginning with addition to DA-
cyclobutane 1-37 with subsequent Conia-ene.
37
 Both conditions however did not afford 
the desired cycloadduct product 1-57. 
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Scheme 1.16 Ring opening and attempted ring closure 
 
 Success was realized when the reaction was conducted using BF3·OEt2 to afford a 
24% yield of an unidentified product. After extensive investigation (see section 1.2.2.3) 
the product formed was not that of a cycloadduct (1-57) but that of dihydrooxepine 1-59 
(Scheme 1.17).  
 
 
Scheme 1.17 Reaction of alkoxy-activated DA-cyclobutane 1-37 and phenylacetylene 
under BF3·OEt2 catalysis 
 
1.2.2.3 - NMR analysis and structural determination 
 The 
1
H NMR spectra displayed inconsistencies to that of the expected 
cycloadduct product where fine structure splitting patterns were observed. Instead, broad 
and indistinct peaks were found. Some key diagnostic signals, such as the ethyl ester 
peaks which, in the cycloadducts, are diastereotopic and had now become homotopic. 
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Additionally, the 
1
H NMR showed a resonance at approximately 3.5 ppm which is 
consistent with a malonate proton, indicating that the ring had not been closed in the 
manner as expected (Figure 1.6). The well defined triplet is clearly visible in the bottom 
portion of Figure 1.6 and not present in the top portion.  
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Figure 1.6 
1
H NMR comparison of cycloadduct 1-38a and product of the reaction of DA-
cyclobutane 1-37 and phenylacetylene 
diastereotopic esters 
triplet at ~3.5ppm 
esters no longer diastereotopic 
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 The structure was confirmed by analysis of 2-D NMR using 
1
H-
1
H and 
1
H-
13
C 
correlation peaks. Key interactions from the heteronuclear multiple bond spectroscopy 
are shown in Figure 1.7 which is consistent with the proposed structure of 1-59 (Figure 
1.7). 
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Figure 1.7 Heteronuclear multiple bond correlation spectrum of 1-59a 
 
 Key correlations peaks which were observed from H
A
 included interaction with a 
quaternary benzylic carbon which was assigned to C-1 and a second peak resulting from 
olefin sp
2
 C-4. The proton denoted as H
B
 showed similar interactions with a quaternary 
carbon and that of an olefinic carbon, albeit with different carbons of the molecule. 
H
B 
H
A 
C
1 
C
2 
C
3 
C
4 
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Proton H
B
 showed correlations with C-2 and C-3. These interactions were key in 
distinguishing the structure and they would not have been present had the reaction 
partners undergone a [4+2] cycloaddition. Additionally, the presence of two olefin proton 
resonances in the 
1
H NMR which would not have appeared in a structure consistent with 
1-57.   
 
1.2.2.4 - Proposed mechanisms 
 A proposed mechanism is presented in Scheme 1.18. This mechanism relies on a 
highly unstable vinyl cation which would rapidly rearrange to the obtained product 
(Scheme 1.18). Initial coordination of the Lewis acid to one of the ester moieties would 
give ring opened intermediate 1-60. Nucleophilic attack of the terminal acetylene to the 
oxocarbenium ion would afford vinyl cationic intermediate 1-61, a highly unstable 
compound, which would rapidly undergo a 1,3-shift to a more stable allylic carbocation 
(1-62). A final proton loss would afford dihydrooxepine 1-59. 
 
 
Scheme 1.18 Proposed mechanism involving a vinyl cation intermediate 
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 Allylic carbocation intermediate 1-62 could undergo a different faith for 
formation of a different cyclobutanediester intermediate (1-63) (Scheme 1.19). If the 
malonyl anion which is highly reactive were to attack the cation, the cyclobutane would 
be generated, however in the presence of additional Lewis acid which could coordinate to 
the diester moiety. The vinylous ether would in turn re-open the cyclobutane to generate 
malonyl anion 1-64 which could subsequently undergo elimination and give 
dihydrooxepine 1-59.  
 
 
Scheme 1.19 Reversible ring closure to allylic carbocation and generation of 1-59 
 
 Although the reaction is completely reversible, the intermediate should all 
eventually end up at the thermodynamic product which is suspected to be 1-59. 
Additional control experiments to identify the proposed intermediate would have been 
futile as the initial ring opening event likely would have difficulty occurring in the 
presence of an additional nucleophile. Alkynes are known to be poor nucleophiles and as 
such the strength of the nucleophile would have to be less than that of an alkyne as to not 
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interrupt the formation of 1-62. The proposed intermediates in the mechanism presented 
in scheme 1.18 and 1.19 are speculative as per the above mention difficulties which 
would be associated with addition of a secondary nucleophile. 
 Although the shift of the C-O bond through a 1,3-migration does lead to the 
dihydrooxepine, if 1-61 had undergone a C-C bond migration an alternative seven 
membered ring structure (1-65) would be generated (Scheme 1.23). Elimination in this 
case would provide access to a different dihydrooxepine (1-66).  
 
 
Scheme 1.20 Alternative THF opening via a C-C bond migration to dihydrooxepine 1-66 
 
 The mechanism presented in Scheme 1.23 does provide a suitable means to access 
the seven-membered ring, and would give similar correlation peaks in the HMBC, 
however the 
1H NMR would look different. The olefin proton α to the oxygen in 1-66 
would be significantly downfield from H
A
 of 1-59 (see Figure 1.7). The chemical shift 
difference should be approximately 1 ppm if dihydrooxepine 1-66 had been formed; 
experimentally the chemical shift in 1-59 was observed at 5.72 ppm (Figure 1.8). 
Additionally, the upfield proton (H
B
) shows correlations in the HMBC with only carbons 
that are sp
2
 hybridized and none that are sp
3
, whereas the downfield proton (H
A
) shows 
correlations with sp
2
 carbons and two additional sp
3
 carbons which are too upfield to be 
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adjacent to the oxygen atom (chemical shifts approximately 40 ppm, whereas the ether 
sp
3
 carbon would be around 65 ppm). These are likely the result of correlations to the two 
allylic carbons (Figure 1.8). Although both olefin protons interact with a different 
quaternary carbon, the absence of a correlation between the downfield olefinic proton and 
that of the sp
3
 ether carbon are in the author’s opinion, key observation that support 1-59a 
over 1-66. 
 
 
Figure 1.8 Chemical shift differences of most downfield olefin proton in 
dihydrooxepines 1-59a and 1-66 and key observed and missing HMBC correlations 
  
 A second potential mechanism is also proposed which does not invoke a 1,3-shift, 
but rather uses the available tetrahydrofuran lone pair to give a highly strained ring 
system (Scheme 1.21).  
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Scheme 1.21 Alternative mechanism for formation of 1-59 
 
 In this proposed second mechanism, opening and nucleophilic attack proceed in 
the same manner as Scheme 1.18 to generate 1-61. The lone pair of the tetrahydrofuran 
would attack the cation to give a highly strained bicyclic intermediate 1-67, which would 
then rapidly open with loss of a proton to afford 1-59. Oxonium ion could also arise from 
a [2+2] cycloaddition of the oxocarbenium ion in 1-60 with the alkyne; however this 
mode of reactivity is likely less favored as it would be symmetry forbidden. 
 Similar mechanisms have been proposed for other types of ring openings.
38
 For 
instance, Snyder’s synthesis of Laurencia-type bromoethers was thought to undergo 
addition of a THF oxygen lone pair. Bromonium ion 1-68 would undergo attack from the 
neighboring THF lone pair to generate a bicyclic oxocarbenium ion 1-69 which can open 
to yield oxocane 1-70 (Scheme 1.22).
38g
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Scheme 1.22 Snyder’s proposed oxonium assisted opening 
 
 Although oxonium ion has a high amount of literature, generation of the highly 
strained oxonium within the unsaturated four-membered ring system (1-67) would be 
highly unfavorable as the ring strain would make this process slower. To that end, I 
believe that our first proposed mechanism is a more plausible means to access the seven-
membered ring. Even with the potential formation of a second cyclobutane ring (1-63) 
this cyclobutane would likely undergo a second ring opening event in the presence of the 
Lewis acid which would also funnel towards dihydrooxepine 1-59. The generation of less 
strained intermediates would give the mechanism proposed in Scheme 1.18 and 1.19 
more validation than generating 1-59 through a strained four-membered ring. 
 
1.2.2.5 - Further optimization of reaction conditions 
 Having generated an interesting product using DA-cyclobutane 1-37, further 
optimization for the formation of 1-59a with phenylacetylene was undertaken (Table 
1.5). 
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Table 1.5 Effect of BF3·OEt2 loading, solvent, and temperature 
 
entry
a BF3·OEt2 
loading 
solvent time 
temp 
(°C) 
yield 
(%)
b 
1 10 mol % CHCl3 30 min 62 24 
2 10 mol % 1,2-DCE 18 h RT 27 
3 10 mol % 1,2-DCE 30 min 40 28 
4 10 mol % 1,2-DCE 15 min 84 33 
5 10 mol % 1,2-DCE 30 min 84 35 
6 1 equiv 1,2-DCE 15 min 84 41 
7 1 equiv 1,2-DCE 1 h rt 20 
8 1 equiv PhMe 15 min 111 38 
9 1 equiv PhH 15 min 80 26 
10 1 equiv MeNO2 15 min 103 16 
11
c 
1 equiv 1,2-DCE 1 min 80 34 
a
 Reaction conditions: 0.4 mmol of 1-37, phenylacetylene (1.1 equiv), solvent (3 mL). 
b
 Isolated yield. 
 
c
 Reaction performed in a microwave reactor. 
 
 Lower yields were obtained in CHCl3 (Table 1.5, entry) and prolonged reaction 
times were needed under ambient conditions (entry 2). Slight heating accelerated the 
reaction substantially (compare entry 2 and 3) and in refluxing 1,2-DCE an increase in 
yield was observed (entry 4 and 5). Increasing the amount of BF3·OEt2 present in the 
reaction saw a modest increase in yield whereas prolonged reaction times with increased 
amount of Lewis acid led to lower yields (compare entry 6 and 7), presumably due to 
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slow decomposition of 1-59a. Changing the solvent to non-halogenated solvents showed 
lower yields of dihydrooxepine 1-59a (entries 8 - 10) and subjecting the reaction to 
microwave irradiation (entry 11) also did not provide 1-59a in any greater amount. 
 Opting for the use of a full equivalent of Lewis acid in refluxing 1,2-DCE, the 
effects of the concentration of the reaction was investigated (Table 1.6). 
 
Table 1.6 Effect of concentration 
 
entry
a concentration of 1-37 
[M] 
yield 
(%)
b 
1 0.1 41 
2 0.06 53 
3
c 
0.06 49 
3 0.05 51 
4 0.03 49 
5 0.02 43 
a
 Each reaction run with 0.4 mmol of 1.37, phenylacetylene (1.1 equiv). 
b
 Average isolated yield of two or more runs. 
c
 2 equiv of BF3·OEt2 used. 
 
 Gratifyingly, decreasing the concentration of DA-cyclobutane resulted in an 
increased yield of 1-59a (Table 1.6, compare entry 1 and 2). Further decreasing the 
concentration of the starting material did not result in an increased yield and for the rest 
of the studies 0.06M of 1-37 in 1,2-DCE was used to study the scope of the reaction. A 
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second source of BF3 was also investigated (BF3·SMe2), however the yield of the product 
was decreased to 35%. 
 
1.2.2.6 - Reaction scope and limitations 
 With the optimized conditions in hand (0.06 M 1-37, 1.1 equiv alkyne, 1 equiv 
BF3·OEt2 in 1,2-DCE), the reaction scope was investigated (Table 1.7). 
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Table 1.7 Scope of the reaction between DA cyclobutane 1-37 and alkynes 
 
entry
a 
R product 
yield 
(%) 
1 Ph 1-59a 53 
2 4-Me-C6H4 1-59b 34 
3 4-Br-C6H4 1-59c 31 
4 4-I-C6H4 1-59d 36 
5 1-naphthyl 1-59e 35 
6 4-AcO-C6H4 1-59f 35 
7 4-MeO-C6H4 - 0
b 
8 4-O2N-C6H4 - 0
b 
9 9-anthracenyl - 0
c
 
10 N-tosyl-3-indolyl - 0
d 
11 N-methyl-3-indolyl - 0
d 
12 n-Bu - 0
b 
a
 Reaction conditions: 0.4 mmol of 1-37, alkyne (1.1 equiv), BF3·OEt2 (1 equiv), 1,2-DCE (6 mL), 
immersed into a pre-heated oil bath. 
b
 1-37 decomposed. 
c
 1-37 decomposed, 71% of alkyne recovered. 
 
d
 1-37 decomposed, >90% of alkyne recovered. 
 
 Electronically neutral alkynes were found to provide 1-59 in the best yields. 
Alkynes that engaged in the reaction were phenyl and tolyl (entries 1 and 2), as well as 4-
bromo and 4-iodo aryl alkynes (entries 3 and 4). Napthyl alkyne was compatible (entry 
5), however further increased steric bulk resulted in decomposition of 1-37 over product 
formation (entry 9). Slight donating substitution on the aryl ring provided 1-59 in 
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moderate yield (entry 6) while electron donating substituents such as methoxy did not 
produce any product (entry 7) likely due to rapid polymerization of the alkyne. Electron-
deficient arylalkynes did not undergo the reaction at all (entry 8). Additionally, 
heteroatom substituted alkynes were also unreactive irrespective of the protecting group 
on the nitrogen (entries 10 and 11) and aliphatic alkynes lead did not afford 1-58 either 
(entry 12). 
 As the electron rich alkyne (2-ethynyl-4-methoxybenzene) rapidly polymerized 
and 1-37 decomposed, it was proposed that decreasing the strength of the Lewis acid 
could provide 1-59 (Scheme 1.23). In this regard, substitution of one of the fluorine 
atoms with a benzyl ether would reduce the reactivity and could allow for the reaction to 
proceed with electron-rich alkynes.
39
 However, to our dismay, treatment of the same 
reaction conditions with the attenuated Lewis acid also lead to rapid decomposition of 1-
37. 
 
 
Scheme 1.23 Attenuated Lewis acid reaction for electron-rich alkynes 
 
 As slightly electron-donating substituents (acetoxy) gave moderate yields of 1-59f 
we investigated silyl protected 4-ethnylphenol. Under the BF3·OEt2 reaction conditions, 
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DA-cyclobutane 1-37 engaged the alkyne in the reaction to afford cycloaddition product 
1-57 as opposed to the expected product 1-59 (Scheme 1.24). This example was the only 
case whereby the cyclohexene product was observed, likely owing to increased 
stabilization of a transition state from the silicon atom allowing ring closure to occur. 
 
 
Scheme 1.24 Reaction of a silyl ether substituted alkyne 
 
 This silyloxy substituted phenylacetylene was the only instance where the desired 
[4+2] cycloadduct. The increased steric bulk about the aryl ring is a reasonable cause for 
the limited polymerization of the alkyne which was observed with the para-methoxy 
variant. This added sterics also would limit the ability of the C-O bond migration and the 
ring expansion observed to the dihydrooxepine. 
 Attempts to broaden the scope of the reaction by using  pyran substituted DA-
cyclobutane 1-44 in the presence of phenylacetylene under the BF3·OEt2 conditions lead 
to rapid decomposition of the starting material without formation of the desired 
rearrangement product 1-70 or cycloaddition product 1-71 (Scheme 1.25). 
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Scheme 1.25 Reaction of an additional DA-cyclobutane 
 
 As DA-cyclobutane 1-44 rapidly decomposed under the reaction conditions, it 
was decided that other cyclobutanes would not be attempted. 
 
1.2.2.7 - Summary 
 In this section, an unexpected reaction of a DA-cyclobutanediester was developed 
and expanded. The unique nature of this reaction is the result of an 
addition/rearrangement procedure which generated dihydrooxepines, which was 
characterized and elucidated through 1-D and 2-D NMR studies. Although the yields 
were moderate in all cases, the fascinating structures which are formed are unique and 
have potential to be applied for the synthesis of complex structures in the future. A 
fascinating and highly unexpected [4+2] cycloadduct product was obtained in the 
presence of a very electron rich silyloxy substituted phenylacetylene whose steric bulk 
likely limited polymerization observed with a para-methoxy substituted phenylacetylene. 
Several potential mechanisms have been provided showing alternate pathways to the 
product. A C-C bond migration would have afforded an alternative dihydrooxepine, 
however 2-D NMR studies did not support the proposed product. The NMR data was 
supportive of dihydrooxepine 1-59. This work presented a very unique reactivity pattern 
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of strained ring system and was the first application of an all-carbon reaction partner with 
alkoxy-activated cyclobutanediesters.   
 
1.3 - Summary of all donor-acceptor work 
 DA-cyclobutanes were used in two separate instances in this chapter. The 
application of aldehydes with DA-cyclobutanes resulted in formation of a bicyclic acetal 
structure with moderate to good yields as single diastereomers, without the need for 
catalyst switching to allow for less reactive aldehydes to be competent dipoles. The 
second section was the first application of all-carbon dipoles to generate unique 
dihydrooxepines from a rearrangement reaction of alkoxy-activated DA-cyclobutanes.  
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1.4 - Experimental  
1.4.1 - General considerations 
 Reaction flasks were either dried in an oven or flame dried under vacuum and 
allowed to cool to room temperature prior to use. Solvents and reagents were purified by 
standard methods.
40
 Dichloromethane, diethyl ether, dimethylformamide, tetrahydrofuran 
and toluene were purified by passing the solvent through an activated alumina column. 
1,2-Dichloroethane was distilled from calcium hydride and stored in a Schlenk flask. 
Aldehydes were distilled and used immediately.  The Bestmann-Ohira reagent was 
prepared according to a literature procedure.
41
 2-Iodoxbenzoic acid was prepared 
according to a literature procedure and stored at -20 °C.
42
 Reaction progress was 
monitored by thin layer chromatography (TLC) performed on F254 silica gel plates. The 
plates were visualized by UV light (254 nm) or by staining with ceric ammonium 
molybdate (CAM),
43
 potassium permanganate or p-anisaldehyde. Column 
chromatography was performed with Silica Flash P60 60Å silica gel purchased from 
Silicycle according to the Still method.
44
 
 The 
1
H and 
13
C NMR spectra were recorded on a Varian 400 or 600 MHz 
spectrometers. Chemical shifts are reported in part per million (ppm), and are referenced 
to residual chloroform at δ 7.25 ppm for 1H NMR spectra and to the center peak of the 
triplet at δ 77.0 ppm for 13C NMR spectra. When peak multiplicities are given, the 
following abbreviations are used: s, singlet; d, doublet; dd, doublet of doublets; dt, 
doublet of triplets; ddd, doublet of doublet of doublets; t, triplet; q, quartet; m, multiplet; 
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br, broad; app, apparent. EI mass spectra were obtained on a Finnigan MAT 8200 
spectrometer with an ionizing voltage of 70 eV. 
 
1.4.2 - Formal [4+2] cycloaddition of donor-acceptor cyclobutanes with aldehydes 
 
 
Diethyl 2-oxabicyclo[3.2.0]heptane-7,7-dicarboxylate (1-37) 
A solution of diethyl malonate (1 equiv), paraformaldehyde (2 equiv), potassium acetate 
(0.1 equiv) and copper (II) acetate (0.05 equiv) in acetic acid was heated to 100 °C for 3 
hours. The approximate volume of acetic acid added was distilled under ambient 
conditions. A vacuum was applied and methylidene malonate was distilled into a flask 
cooled to -78 °C. The crude solution was diluted with Et2O and washed twice with 
NaHCO3. The organic layer was dried over MgSO4, filtered and concentrated under 
reduced pressure. The crude methylidene malonate was used without further purification.  
Crude methylidene diethylmalonate (1 equiv) was taken up in CH2Cl2 (0.4 M) at -78 °C 
and added 2,3-dihydrofuran (1.2 equiv). Using a cannula, the reaction mixture was 
transferred via cannula to a solution of Zn(OTf)2 (0.05 equiv) in CH2Cl2 (0.2 M) at room 
temperature and stirred for 1.5 hours. Once time had elapsed, the mixture was filtered 
through a plug of Celite, washed with CH2Cl2 and concentrated under reduced pressure. 
The residue was purified by flash column chromatography to afford a clear colorless oil 
(60 - 82%).  Rf 0.57 (4:1 hexanes/EtOAc); 
1
H NMR (CDCl3, 600 MHz) δ 4.98 - 4.97 (m, 
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1H), 4.30 - 4.13 (m, 4H), 4.10 - 4.07 (m 1H), 3.99 - 3.95 (m, 1H), 3.13 - 3.09 (m, 1H), 
2.50 (dd, J = 13.5, 7.0 Hz, 1H)), 2.31 - 2.27 (m, 1H), 1.82 - 1.74 (m, 2H), 1.26 - 1.23 (m, 
6H); 
13
C NMR (CDCl3, 101 MHz) δ 170.7, 168.0, 81.7, 69.5, 61.3, 56.3, 35.9, 31.0, 29.3, 
14.0. 
 
General reaction procedure for Yb(OTf)3 catalyzed cycloadditions with aldehydes 
A solution of Yb(OTf)3 (0.042 mmol, 10 mol %) in CH2Cl2 (2 mL) at 0 °C was added 
aldehyde (0.45 mmol, 1.1 equiv) followed by the subsequent addition of cyclobutane 
(0.41 mmol, 1 equiv). The progressed was monitored by TLC and after the cyclobutane 
had been consumed (15 min) the reaction was flushed through a plug of SiO2. The plug 
was washed with CH2Cl2 (2 mL) and the solvent was removed under reduced pressure. 
The crude reaction product was purified using standard flash column chromatography 
(hexanes/EtOAc) to give the pure cycloadducts. 
 
 
(6R,7aR)-Diethyl 6-phenyltetrahydro-2H-furo[2,3-b]pyran-5,5(3H)-dicarboxylate  
(1-38a) 
The title compound was prepared according to the general cycloaddition procedure with 
aldehydes to afford a yellow oil (78%, 111 mg). Rf  0.14 (5:1 hexanes/EtOAc); 1H NMR 
(CDCl3, 600 MHz) δ 7.35 (d, J = 8.2 Hz, 2 H), 7.23 - 7.17 (m, 3 H), 5.44 (s, 1 H), 5.26 
(d, J = 4.7 Hz, 1 H), 4.30 - 4.25 (m, 1 H), 4.22 - 4.17 (m, 1 H), 4.13 - 4.09  (m, 1 H), 3.67 
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- 3.59 (m, 2H),  3.34 (dq, J = 10.8, 7.1 Hz, 1 H), 2.42 - 2.38 (m, 1H), 2.33 (dd, J = 13.5, 
5.9 Hz, 1 H), 2.19 - 2.14 (m, 1 H), 2.12 - 2.06 (m, 1 H), 1.77 - 1.73 (m, 1 H), 1.23 (t, J = 
7.3 Hz, 3 H), 0.80 (t, J = 7.0 Hz, 3 H); 
13
C NMR (CDCl3, 101 MHz) δ 171.3, 169.1, 
138.2, 128.0, 127.5, 127.3, 102.2, 75.5, 67.4, 61.8, 61.1, 59.2, 36.0, 31.4, 30.1, 14.0, 
13.4; HRMS m/z 348.1583 (calcd for C19H24O6, 348.1573). 
 
 
(3aR*,6R*,7aR*)-Diethyl 6-(4-cyanophenyl)-tetrahydro-2H-furo[2,3-b]pyran-
5,5(3H)-dicarboxylate (1-38d) 
The title compound was prepared according to the general cycloaddition procedure with 
aldehydes to afford a yellow oil (88%, 135 mg). Rf 0.18 (4:1 hexanes/EtOAc); 
1
H NMR 
(CDCl3, 400 MHz) δ 7.54 (d, J = 8.8 Hz, 2H), 7.52 (d, J = 8.8 Hz, 2H), 5.40 (s, 1H), 5.25 
(d, J = 5.3 Hz, 1H), 4.29 - 4.20 (m, 2H), 4.14 - 4. 10 (m, 2H), 3.96 (dt, J = 8.2, 4.1 Hz, 
1H), 3.72 - 3.66 (m, 1H), 3.48 - 3.43 (m, 1H), 2.43 (dd, J = 13.5, 10.5 Hz, 1H), 2.38 (dd, 
J = 14.0, 6.4 Hz, 1H), 2.24 - 2.18 (m, 1H), 2.14 - 2.08 (m, 1H), 1.81 - 1.77 (m, 1H), 1.24 
(t, J = 7.6 Hz, 3H), 0.86 (t, J = 7.3 Hz, 3H); 
13
C NMR (CDCl3, 101 MHz) δ 170.8, 168.6, 
143.5, 131.2, 128.1, 118.6, 111.5, 102.6, 74.9, 67.6, 62.1, 61.2, 59.0, 35.8, 30.8, 30.3, 
13.9, 13.4; HRMS m/z 373.1527 (calcd for C20H23NO6, 373.1525). 
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(3aR*,6R*,7aR*)-Diethyl 6-(naphthalen-1-yl)-tetrahydro-2H-furo[2,3-b]pyran-
5,5(3H)-dicarboxylate (1-38f) 
The title compound was prepared according to the general cycloaddition procedure with 
aldehydes to afford a yellow oil (80%, 131 mg). Rf 0.25 (5:1 hexanes/EtOAc); 
1
H NMR 
(CDCl3, 400 MHz) δ 8.23 (d, J = 8.6 Hz, 1H), 7.78 - 7.70 (m, 3H), 7.50 - 7.35 (m, 3H), 
6.49 (s, 1H), 5.38 (d, J = 4.7 Hz, 1H), 4.38 - 4.16 (m, 3H), 4.02 - 3.98 (m, 1H), 3.31 - 
3.22 (m, 1H), 2.65 - 2.57 (m, 1H), 2.51 - 2.45 (m, 1H), 2.38 - 2.34 (m, 1H), 2.27 - 2.13 
(m, 2H), 1.81 - 1.78 (m, 1H), 1.24 (t, J = 7.0 Hz, 3H), 0.19 (t, J = 7.0 Hz, 3H); 
13
C NMR 
(CDCl3, 101 MHz) δ 171.3, 169.0, 134.4, 133.1, 131.2, 128.3, 128.2, 125.7, 125.2, 125.1, 
124.4, 102.1, 70.9, 67.3, 61.9, 60.1, 59.3, 36.1, 31.8, 30.3, 14.0, 12.4; HRMS m/z 
398.1737 (calcd for C23H26O6, 398.1729). 
 
 
(3aR*,6R*,7aR*)-Diethyl 6-(furan-2-yl)-tetrahydro-2H-furo[2,3-b]pyran-5,5(3H)-
dicarboxylate (1-38j) 
The title compound was prepared according to the general cycloaddition procedure with 
aldehydes to afford a yellow oil (71%, 98 mg). Rf 0.32 (5:1 hexanes:EtOAc); 
1
H NMR 
(CDCl3, 400 MHz) δ 7.27 (s, 1H), 6.32-6.31 (m, 1H), 6.27 - 6.26 (m, 1H), 5.46 (s, 1H), 
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5.26 (d, J = 4.7 Hz, 1H), 4.30 - 4.15 (m, 2H), 4.08 (app q, J = 8.0 Hz, 1H), 3.98 - 3.90 
(m, 1H), 3.88 - 3.78 (m, 2H), 2.50 (dd, J = 13.7, 9.0 Hz, 1H), 2.42 (dd, J = 13.7, 6.2 Hz, 
1H), 2.20 - 2.13 (m, 1H), 2.08 - 2.00 (m, 1H), 1.84 - 1.77 (m, 1H), 1.23 (t, J = 8.0 Hz, 
3H), 1.00 (t, J = 8.0 Hz, 3H); 
13
C NMR (CDCl3, 101 MHz) δ 170.4, 168.8, 151.3, 141.6, 
110.1, 108.3, 101.7, 70.7, 67.5, 62.0, 61.4, 56.8, 36.0, 30.0, 29.6, 13.9, 13.6; HRMS m/z 
338.1368 (calcd for C17H22O7, 338.1366). 
 
 
1-Tosyl-1H-indole-3-carboxaldehyde 
To a solution of indole-3-carboxaldehyde (2.16 g, 15 mmol) in DMF (20 mL) at 0 °C was 
added dry NaH (418 mg, 17.2 mmol). The reaction was stirred for 1 h after which TsCl 
(3.44 g, 18 mmol) was added and allowed to stir overnight at RT. The reaction was 
quenched by the addition of a solution of half-saturated NH4Cl (10 mL). The aqueous 
layer was extracted with EtOAc (3 x 10 mL). The combined organic extracts were 
washed with brine, dried (MgSO4), filtered through a pad of Celite and concentrated 
under reduced pressure. The crude reaction mixture was purified by flash column 
chromatography (hexanes/EtOAc) to give the protected indole as a yellow solid (2.38 g, 
8.0 mmol, 53%). Rf 0.45 (30% EtOAc/hexanes); 
1
H NMR (CDCl3, 400 MHz) δ 10.1 (s, 
1H), 8.26 - 8.24 (m, 2H), 7.95 (d, J = 8.2 Hz, 1H), 7.86 (d, J = 8.6 Hz, 2H), 7.43 - 7.34 
(m, 2H), 7.30 - 7.26 (m, 2H), 2.37 (s, 3H); 
13
C NMR (CDCl3, 150 MHz) δ 185.3, 146.1, 
136.2, 135.2, 130.3, 127.2, 126.2, 125.0, 122.6, 122.3, 113.2, 110.0, 21.6.   
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(3aR*,6R*,7aR*)-Diethyl 6-(1-tosyl-1H-indol-1-yl)-tetrahydro-2H-furo[2,3-b]pyran-
5,5(3H)-dicarboxylate (1-38l) 
The title compound was prepared according to the general cycloaddition procedure with 
aldehydes to afford a yellow solid (81%, 179 mg). Rf 0.19 (3:2 hexanes/EtOAc); 
1
H 
NMR (CDCl3, 600 MHz) δ 7.88 (d, J = 8.2 Hz, 1H), 7.72 (d, J = 8.8 Hz, 2H), 7.62 (s, 
1H), 7.60 (d, J = 8.2 Hz, 1H), 7.22 (d, J = 7.6 Hz, 1H), 7.18 - 7.14 (m, 3H), 5.71 (s, 1H), 
5.24 (d, J = 5.3 Hz, 1H), 4.25 - 4.13 (m, 3H), 3.97 - 3.94 (m, 1H), 3.39 - 3.33 (m, 1H), 
2.89 - 2.83 (m, 1H), 2.49 (dd, J = 13.5, 11.1, 1H), 2.36 (dd, J = 14.0, 6.4 Hz, 1H), 2.29 (s, 
3H), 2.24 - 2.18 (m, 1H), 2.15 - 2.08 (m, 1H), 1.87 - 1.83 (m, 1H), 1.17 (t, J = 7.0 Hz, 
3H), 0.42 (t, J = 7.0 Hz, 3H); 
13
C NMR (CDCl3, 150 MHz) δ 170.9, 168.9, 144.7, 135.1, 
134.3, 129.7, 129.5, 126.9, 125.0, 124.4, 123.0, 121.1, 120.0, 113.2, 102.4, 70.1, 67.6, 
61.9, 60.9, 58.5, 36.0, 30.8, 30.1, 21.4, 13.9; HRMS m/z 541.1782 (calcd for 
C28H31NO8S, 541.1770). 
 
 
(3aR*,6R*,7aR*)-Diethyl 6-methyl-tetrahydro-2H-furo[2,3-b]pyran-5,5(3H)-
dicarboxylate (1-38p) 
The title compound was prepared according to the general cycloaddition procedure with 
aldehydes to afford a yellow oil (51%, 61 mg). Rf 0.20 (5:1 hexanes/EtOAc); 
1
H NMR 
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(CDCl3, 400 MHz) δ 5.12 (d, J = 4.3 Hz, 1H), 4.25 - 4.15 (m, 5H), 4.05 (app q, J = 7.8 
Hz, 1H), 3.84 (app q, J = 7.4 Hz, 1H), 2.38 (dd, J = 14.1, 7.4 Hz, 1H), 2.30 (dd, J = 14.1, 
6.2 Hz, 1H), 2.16 - 2.07 (m, 1H), 2.00 - 1.91 (m, 1H), 1.86 - 1.78 (m, 1H), 1.34 (t, J = 6.6 
Hz, 3H), 1.26 (t, J = 7.1 Hz, 3H); 
13
C NMR (CDCl3, 101 MHz) 170.9, 169.7, 102.0, 71.0, 
67.5, 61.3, 56.3, 35.9, 29.9, 29.7, 17.8, 14.0; HRMS m/z 287.1503 (calcd for C14H22O6 + 
H
+
, 287.1489). 
 
1.4.3 - Reactions of donor-acceptor cyclobutanes with alkynes 
Preparation of alkynes using the Bestmann-Ohira reagent: To a solution of aldehyde 
(1 equiv) in MeOH (0.1 M) was added K2CO3 (1.5 equiv) followed by Bestmann-Ohira 
reagent (1.5 equiv). The mixture was allowed to stir at RT overnight, after which a half 
saturated solution of NaHCO3 was added and the aqueous layer was extracted with 
CH2Cl2 (3 x 10 mL). The combined organic extracts were washed with brine, dried 
(MgSO4), filtered through a pad of Celite and concentrated under reduced pressure. The 
crude reaction mixture was purified by flash column chromatography (hexanes/EtOAc) to 
afford the corresponding alkyne. 
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1-Ethynyl-4-methoxybenzene 
The title compound was prepared according to the Bestmann-Ohira procedure to give the 
alkyne as a yellow oil (257 mg, 76 %). Rf 0.85 (9:1 hexanes/EtOAc); 
1
H NMR (CDCl3, 
600 MHz) δ 7.44 (d, J = 8.8 Hz, 2H), 6.82 (d, J = 9.4 Hz, 2H), 3.74 (s, 3H), 3.06 (s, 1H); 
13
C NMR (CDCl3, 150 MHz) δ 159.7, 133.3, 114.0, 113.7, 83.5, 75.8, 54.9. 
 
 
1-Ethynyl-4-methylbenzene 
The title compound was prepared according to the preparation of alkynes using the 
Bestmann-Ohira reagent as a yellow oil (103 mg, 71%). Rf 0.83 (9:1 hexanes/EtOAc). 
1
H 
and 
13
C NMR data is consistent with previously reported values.
45
 
 
 
1-Bromo-4-ethynylbenzene 
The title compound was prepared according to the procedure using the Bestmann-Ohira 
reagent to provide the alkyne as an orange solid (270 mg, 68%). Rf 0.78 (4:1 
hexanes/EtOAc). 
1
H and 
13
C NMR data is consistent with previously reported literature 
values.
46
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1-Ethynylnaphthalene 
The title compound was prepared according to the Bestmann-Ohira procedure to provide 
the alkyne as a dark brown oil (436 mg, 95 %). Rf 0.82 (9:1 hexanes/EtOAc). 
1
H and 
13
C 
NMR data are consistent with previously reported literature values.
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1-Ethynyl-4-nitrobenzene 
The title compound was prepared according to the Bestmann-Ohira procedure to give the 
alkyne as an off-white solid (294 mg, 95%). Rf 0.80 (9:1 hexanes/EtOAc). 
1
H and 
13
C 
NMR data are consistent with the previously reported literature values.
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1-Ethynyl-4-iodobezene 
(4-Iodophenyl)methanol was prepared from a literature procedure
48
 from methyl-4-
iodobenzoate as an orange solid (456 mg, 95%). A solution of (4-iodophenyl)methanol 
(392 mg, 1.68 mmol, 1 equiv) in EtOAc (4 mL) was added 2-iodoxybenzoic acid (1.43 g, 
5.11 mmol, 3 equiv) and heated to 80 °C. Once the alcohol was consumed by TLC (2 h), 
the reaction was cooled to 0 °C in an ice bath and stirred for 1 h. The precipitate was 
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filtered through a pad of Celite and the filtrate concentrated under reduced pressure. The 
crude reaction mixture was purified by flash column chromatography to afford 4-
iodobenzaldehyde as an orange solid (389 mg, 96 %). The aldehyde was then subjected to 
the Bestmann-Ohira procedure to provide the alkyne as an orange solid (360 mg, 94 %). 
Rf 0.83 (9:1 hexanes/EtOAc); 
1
H NMR (CDCl3, 600 MHz) δ 7.66 (d, J = 8.8 Hz, 2H), 
7.20 (d, J = 8.2 Hz, 2H), 3.12 (s, 1H); 
13
C NMR (CDCl3, 150 MHz) δ 137.5, 133.6, 
121.6, 94.8, 82.7, 78.6; HRMS m/z 227.9429 (calcd for C8H5I, 227.9436). 
 
 
4-Ethynylphenyl acetate 
4-Ethynylphenol was prepared according to a literature procedure from tert-butyl(4-
ethynylphenoxy)dimethylsilane.
49
 Crude 4-ethynylphenol was acetylated according to a 
literature procedure
50
 to give the alkyne as a clear oil (88 mg, 47 %, 2 steps). Rf 0.62 (4:1 
hexanes/EtOAc); 
1
H NMR (CDCl3, 600 MHz) δ 7.49 (d, J = 8.8 Hz, 2H), 7.05 (d, J = 8.8 
Hz, 2H), 3.05 (s, 1H), 2.29 (s, 3H); 
13
C NMR (CDCl3, 150 MHz) δ 169.0, 150.8, 133.3, 
121.6, 119.7, 82.8, 77.2, 21.1; HRMS m/z 160.0530 (calcd for C10H8O2, 160. 0524). 
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9-Ethynylanthracene 
The title compound was prepared according to a literature procedure
51
 as an off-white 
solid (177 mg, 87%). Rf 0.73 (9:1 hexanes/EtOAc); 
1
H NMR (CDCl3, 600 MHz) δ 8.60 
(d, J = 8.2 Hz, 2H), 8.44 (s, 1H), 8.00 (d, J = 8.2 Hz, 2H), 7.60 (t, J = 7.6 Hz, 2H), 7.51 
(t, J = 7.6 Hz, 2H), 4.00 (s, 1H); 
13
C NMR (CDCl3, 150 MHz) δ 133.1, 131.0, 128.6, 
128.2, 126.8, 126.5, 125.6, 116.0, 88.2, 80.3; HRMS m/z 202.0786 (calcd for C16H10, 
202.0783). 
 
 
3-Ethynyl-1-tosyl-1H-indole 
1-Tosyl-1H-indole-3-carbaldehyde was prepared from a literature procedure
52
 to afford 
an off-white solid (2.13 g, 75%). The title compound was prepared from 1-tosyl-1H-
indole-3-carbaldehyde according to a literature procedure
53
 to afford 3-ethynyl-1-tosyl-
1H-indole (932 mg, 72%) as a light brown solid.  Rf 0.81 (9:1 hexanes/EtOAc). 
1
H and 
13
C NMR data are consistent with previously reported literature values. 
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tert-Butyl(4-ethynylphenoxy)dimethylsilane 
A solution of 4-hydroxybenzaldehyde (1.07 g, 8.8 mmol) in CH2Cl2 (40 mL) was added 
imidazole (1.50 g, 22 mmol) and TBSCl (1.58 g, 10.5 mmol) and stirred 15 min. The 
reaction was diluted with CH2Cl2 (20 mL) and washed with H2O (20 mL) and brine (20 
mL). Organic layer was dried (MgSO4), filtered through a pad of Celite and concentrated 
under reduced pressure. The crude reaction mixture was purified by column 
chromatography to afford TBS-protected benzaldehyde as a yellow oil (2.00 g, 96%). 4-
(tert-Butyldimethylsilyloxy)benzaldehyde was converted to the title compound by a 
Corey-Fuchs protocol following a literature procedure
53
 as a yellow oil (943 mg, 80% 
over 2 steps). Rf 0.92 (9:1 hexanes/EtOAc); 
1
H NMR (CDCl3, 600 MHz) δ 7.36 (d, J = 
8.2 Hz, 2H), 6.77 (d, J = 8.8 Hz, 2H), 2.98 (s, 1H), 0.97 (s, 9H), 0.19 (s, 6H); 
13
C NMR 
(CDCl3, 150 MHz) δ 156.3, 133.6, 120.1, 114.8, 83.7, 75.9, 25.6, -4.4; HRMS m/z 
232.1278 (calcd for C14H20OSi, 232.1283). 
 
General procedure for the BF3·OEt2 mediated reaction of donor-acceptor 
cyclobutanes with terminal alkynes: A solution of cyclobutane 1-37 (0.4 mmol, 1 
equiv) and alkyne (1.1 equiv) in 1,2-dichloroethane (6 mL, 0.1 M) was added BF3·OEt2 
(50 μL, 0.4 mmol, 1 equiv). A reflux condenser was attached and the reaction flask was 
placed into an oil bath preheated to 90 °C. After consumption of the cyclobutane by TLC, 
the reaction mixture was poured into a separatory funnel containing a half saturated 
solution of NaHCO3. The aqueous phase was extracted with three portions of CH2Cl2 (5 
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mL) and the combined organics extracts were washed with brine, dried over MgSO4, 
filtered through a pad of Celite and concentrated under reduced pressure. The crude 
residue was purified using flash column chromatography (4:1 hexanes/EtOAc). 
 
 
Diethyl 6-(4-(tert-butyldimethylsiloxy)phenyl)-2,3,3a,4-tetrahydrobenzofuran-
5,5(7aH)-dicarboxylate (1-57) 
The title compound was obtained from the BF3·OEt2 mediated reaction procedure to 
provide the product as a yellow oil (38 mg, 20%). Rf 0.60 (4:1 hexanes/EtOAc); 
1
H NMR 
(CDCl3, 600 MHz) δ 7.25 (d, J = 7.6 Hz, 2H), 6.70 (d, J = 8.8 Hz, 2H), 6.08 (d, J = 3.5 
Hz, 1H), 4.30 (q, J = 7.0 Hz, 2H), 4.19 - 4.15 (m, 2H), 4.01 - 3.98 (m, 1H), 3.86 - 3.81 
(m, 1H), 3.80 - 3.74 (m, 1H), 3.73 - 3.69 (m, 1H), 2.39 (dd, J = 12.6, 4.4 Hz, 1H), 2.33 - 
2.27 (m, 1H), 2.26 - 2.21 (m, 1H), 2.04 - 1.96 (m, 1H), 1.31 (t, J = 7.3 Hz, 3H), 0.94 (s, 
9H), 0.82 (t, J = 7.0 Hz, 3H); 
13
C NMR (CDCl3, 101 MHz) δ 170.6, 170.4, 155.1, 140.2, 
133.3, 129.3, 127.4, 119.4, 74.0, 66.9, 61.8, 61.4, 60.8, 34.8, 33.0, 32.9, 25.7, 18.2, 
14.1,13.5, -4.4; HRMS m/z 474.2448 (calcd for C26H38O6Si, 474.2438). 
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Diethyl 2-(((4Z,6Z)-7-phenyl-2,3-dihydrooxepin-4-yl)methyl) malonate (1-59a) 
The title compound was prepared according to the BF3·OEt2 mediated procedure to 
provide the product as a yellow oil (79 mg, 53%). Rf 0.49 (4:1 hexanes/EtOAc); 
1
H NMR 
(CDCl3, 600 MHz) δ 7.56 - 7.55 (m, 2H), 7.31 - 7.29 (m, 2H), 7.27 - 7.25 (m, 1H), 5.72 
(d, J = 8.8 Hz, 1H), 5. 53 (d, J = 8.8 Hz, 1H), 4.32 (app t, J = 4.1 Hz, 2H), 4.19 (q, J = 7.0 
Hz, 4H), 3.55 (t, J = 7.9 Hz, 1H), 2.73 (d, J = 8.2 Hz, 2H), 2.62 (app t, J = 4.1 Hz, 2H), 
1.25 (t, J = 7.0 Hz, 6H); 
13
C NMR (CDCl3, 101 MHz) δ 169.0 (2), 157.4, 137.5, 137.0, 
128.3, 128.1, 125.3, 122.1, 99.1, 69.0, 61.5, 51.0, 38.8, 37.1, 14.1; HRMS m/z 344.1617 
(calcd for C20H24O5, 344.1624). 
 
 
Diethyl 2-(((4Z,6Z)-7-p-tolyl-2,3-dihydrooxepin-4-yl)methyl) malonate (1-59b) 
The title compound was obtained using the BF3·OEt2 mediated reaction conditions to 
provide the product as a yellow oil (50 mg, 35%). Rf 0.47 (4:1 hexanes/EtOAc); 
1
H NMR 
(CDCl3, 400 MHz) δ 7.45 (d, J = 8.2 Hz, 2H), 7.11 (d, J = 7.8 Hz, 2H), 5.70 (d, J = 8.2 
Hz, 1H), 5.49 (d, J = 8.2 Hz, 1H), 4.31 (app t, J = 4.3 Hz, 2H), 4.18 (q, J = 7.2 Hz, 4H), 
3.55 (t, J = 8.0 Hz, 1H), 2.72 (d, J = 7.8 Hz, 2H), 2.61 (app t, J = 4.1 Hz, 2H), 2.33 (s, 
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3H), 1.25 (t, J = 7.0 Hz, 6H); 
13
C NMR (CDCl3, 101 MHz) δ 169.0, 157.6, 138.0, 136.9, 
134.2, 128.8, 125.2, 122.2, 98.4, 69.0, 61.4, 51.1, 38.8, 37.1, 21.2, 14.1; HRMS m/z 
358.1767 (calcd for C21H26O5, 358.1780). 
 
 
Diethyl 2-(((4Z,6Z)-7-(4-bromophenyl)-2,3-dihydrooxepin-4-yl)methyl) malonate  
(1-59c) 
The title compound was obtained from the BF3·OEt2 mediated reaction procedure to give 
the product as a yellow oil (57 mg, 34%). Rf 0.48 (4:1 hexanes/EtOAc); 
1
H NMR 
(CDCl3, 600 MHz) δ 7.42 (s, 4H), 5.70 (d, J = 7.6 Hz, 1H), 5.52 (d, J = 8.2 Hz, 1H), 4.30 
(app t, J = 4.1 Hz, 2H), 4.18 (q, J = 7.2 Hz, 4H), 3.54 (t, J = 7.9 Hz, 1H), 2.72 (d, J = 8.2 
Hz, 2H), 2.61 (app t, J = 4.1 Hz, 2H), 1.25 (t, J = 6.7 Hz, 6H); 
13
C NMR (CDCl3, 150 
MHz) δ 168.9, 156.3, 138.2, 135.9, 131.2, 126.8, 122.0, 121.9, 99.5, 69.0, 61.5, 51.0, 
38.7, 37.1, 14.1; HRMS m/z 422.0731 (calcd for C20H23BrO5, 422.0729). 
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Diethyl 2-(((4Z,6Z)-7-(4-iodophenyl)-2,3-dihydrooxepin-4-yl)methyl) malonate  
(1-59d) 
The title compound was obtained from the BF3·OEt2 mediated reaction procedure to 
provide the product as a yellow oil (67 mg, 36%). Rf 0.58 (4:1 hexanes/EtOAc); 
1
H NMR 
(CDCl3, 600 MHz) δ 7.61 (d, J = 8.8 Hz, 2H), 7.28 (d, J = 8.8 Hz, 2H), 5.69 (d, J = 8.2 
Hz, 1H), 5.52 (d, J = 8.2 Hz, 1H), 4.29 (app t, J = 4.1 Hz, 2H), 4.18 (q, J = 7.0 Hz, 4H), 
3.54 (t, J = 7.9 Hz, 1H), 2.72 (d, J = 7.6 Hz, 1H), 2.60 (app t, J = 4.1 Hz, 2H), 1.24 (t, J = 
7.0 Hz, 6H); 
13
C NMR (CDCl3, 150 MHz) δ 168.9, 156.3, 138.3, 137.2, 136.5, 127.0 (2), 
121.8, 99.5, 93.6, 69.0, 61.4, 51.0, 38.7, 37.4, 14.1; HMRS m/z 470.0598 (calcd for 
C20H23IO5, 470.0590). 
 
 
Diethyl 2-(((4Z,6Z)-7-(napthalen-1-yl)-2,3-dihydrooxepin-4-yl)methyl) malonate  
(1-59e) 
The title compound was obtained from the BF3·OEt2 mediated reaction procedure to 
provide the product as a yellow oil (58 mg, 35%). Rf 0.50 (4:1 hexanes/EtOAc); 
1
H NMR 
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(CDCl3, 400 MHz) δ 8.09 (d, J = 7.8 Hz, 1H), 7.84 - 7.79 (m, 2H), 7.55 - 7.45 (m, 3H), 
7.44 - 7.39 (m, 1H), 5.73 (d. J = 8.6 Hz, 1H), 5.26 (d, J = 8.2 Hz, 1H), 4.45 (app t, J = 4.3 
Hz, 2H), 4.23 (q, J = 7.0 Hz, 4H), 3.60 (t, J = 7.8 Hz, 1H), 2.77 (d, J = 8.2 Hz, 2H), 2.71 
(app t, J = 4.3 Hz, 2H), 1.29 (t, J = 7.2 Hz, 6H); 
13
C NMR (CDCl3, 101 MHz) δ 169.0, 
158.4, 137.3, 136.3, 133.7, 131.8, 128.8, 128.2, 126.6, 126.0, 125.8, 125.7, 125.0, 122.1, 
103.5, 69.0, 61.5, 51.0, 38.7, 37.2, 14.1; HRMS m/z 394.1772 (calcd for C24H26O5, 
394.1780). 
 
 
Diethyl 2-(((4Z,6Z)-7-(4-acetoxyphenyl)-2,3-dihydrooxepin-4-yl)methyl) malonate  
(1-59f) 
The title compound was obtained from the BF3·OEt2 mediated reaction procedure to 
provide the product as a yellow oil (63 mg, 35%). Rf 0.35 (4:1 hexanes/EtOAc); 
1
H NMR 
(CDCl3, 600 MHz) δ 7.56 (d, J = 8.8 Hz, 2H), 7.02 (d, J = 8.8 Hz, 2H), 5.70 (d, J = 8.2 
Hz, 1H), 5.49 (d, J = 8.8 Hz, 1H), 4.30 (app t, J = 4.3 Hz, 2H), 4.18 (q, J = 7.0 Hz, 4H), 
3.54 (t, J = 7.9 Hz, 1H), 2.72 (d, J = 7.6 Hz, 2H), 2.61 (app t, J = 4.1 Hz, 2H), 2.28 (s, 
3H), 1.24 (t, J = 7.0 Hz, 6H); 
13
C NMR (CDCl3, 150 MHz) δ 169.3, 168.9, 156.7, 150.5, 
137.6, 134.7, 126.3, 122.0, 121.2, 99.2, 69.0, 61.4, 51.0, 38.7, 37.1, 21.1, 14.1; HRMS 
m/z 402.1679 (calcd for C22H26O7, 402.1679). 
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Chapter 2 - Progress Towards Biselide A 
 This chapter will discuss the application of a group developed second generation 
cobalt catalyst for the oxidative formation of trans-2,5-tetrahydrofurans. An overview 
and application of these types of cobalt catalyzed cyclizations will be presented, along 
with previous work towards the syntheses of the haterumalides and related natural 
products. This project was initially started by Barbora Morra, PhD and was continued by 
the author. The compounds presented have been independently synthesized by the author.  
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2.1 - Introduction 
 Tetrahydrofurans (THF) are a highly prevalent structure very common in natural 
products.
1
 Many highly complex macrolides contain the THF functionality and thus 
methods for the facile access of this key moiety are of great importance for scientists. For 
instance, some representative natural products with trans-2,5-THFs are biselide A (2-1), 
E (2-2), bullatacin (2-3) and aplysiallene (2-4) (Figure 2.1).
1
 
 
 
Figure 2.1 Example of trans-2-5-THF containing natural products 
 
2.1.1 - Cobalt-Catalyzed Oxidative Cyclization  
 Mukaiyama, discovered that in the presence of molecular oxygen using a catalytic 
amount of Co(tfa)2 could be cyclized however in low yields.
2
 A few years later, it was 
reported that a variation on his previous catalyst, was now able to cyclize terminal 
alkenes in much greater yield to exclusively the trans-diastereomer.
3
 Using Co(modp)2 in 
catalytic amount, terminal alkenes (2-5) were oxidatively cyclized under molecular 
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oxygen with tert-butyl hydrogen peroxide to trans-2,5-THFs (2-6) in moderate to good 
yields with excellent diastereoselectivity (Scheme 2.1). 
 
 
Scheme 2.1 Mukaiyama’s oxidative cyclization 
 
 The origin of the diastereoselectivity has been the subject of a mechanistic 
investigation by Hartung.
4
 It has been proposed that an initial activation of cobalt species 
2-7 by molecular oxygen would generate an oxygen-centered radical 2-8. This oxidized 
cobalt can then interact with alcohol 2-9 to give coordinated cobalt complex 2-10 which 
in turn based on sterics would orient itself in a chair-like configuration. Radical cation 2-
11 is formed by reduction of the cobalt centre to Co (II), leaving a positive charge which 
can be attacked the hydroxyl oxygen to form cobalt-coordinated THF 2-12 which can 
pick up a hydrogen atom to furnish trans-THF 2-6 (Scheme 2.2). 
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Scheme 2.2 Proposed mechanism and origin of diastereoselectivity 
  
 A fundamental problem exists when applying the modp ligand for the synthesis of 
trans-THFs; the catalyst is almost impossible to remove from the crude reaction mixture 
once the pentenol has been consumed. The Pagenkopf group looked at solving this 
problem by altering the ligand on the cobalt center. 
 
2.1.2 - A 2nd Generation Water Soluble Cobalt Catalyst 
 In 2009, a water soluble catalyst was developed in the Pagenkopf group which 
can now be easily removed from the reaction mixture. The application of the nmp ligand 
provides a much more polar complex that increases its water solubility and is easily 
removed from the reaction mixture by aqueous work-up or by removal of the volatiles 
and filtration.
5
 In all cases, pentenols 2-12 are cyclized to the corresponding trans-THFs 
2-6 and can be isolated pure without the need for column chromatography (Scheme 2.3). 
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The substrate scope is very broad and especially useful when oxidatively labile or acid 
sensitive groups are present on the pentenol starting material. Additionally, as the catalyst 
is easily removed from the reaction mixture, the yields are consistently high (83 - 95%) 
without paramagnetic cobalt species in the products.  
 
 
Scheme 2.3 Pagenkopf’s water soluble nmp ligand and selected synthesized THFs 
 
2.1.3 - Application of the Oxidative Cyclization in Total Synthesis 
 Mukaiyama’s oxidative cyclization to trans-THFs has been applied in a variety of 
total syntheses of complex natural products.
6
 The first application in total synthesis of the 
Mukaiyama oxidative cyclization in the Pagenkopf group came in 2006. Bullatacin was 
synthesized in 13.3% overall yield in this report (Scheme 2.4).
7
 Bis-epoxide 2-13 was 
opened in the presence of allylmagnesium bromide to give diol 2-14 which could be 
desymmetrized to pentenol 2-15 which was prepared for cyclization with Co(modp)2. 
THF 2-16 was converted to a second pentenol 2-17 which underwent an oxidatively 
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cyclization to bis-THF fragment 2-18. The bis-THF fragment could be manipulated in 10 
more steps to bullatacin (2-3). 
 
 
Scheme 2.4 Pagenkopf and co-workers’ synthesis of bullatacin 
 
 A second application came in 2007 when the total synthesis of (-)-aplysiallene 
was accomplished using Mukaiyama’s oxidative cyclization (Scheme 2.5).8 The THF-
core of the target was synthesized from bis-epoxide 2-19 which opened with 
vinylmagnesium bromide to diol 2-20. Acetylation of one hydroxyl to pentenol 2-21 gave 
a substrate which was cyclized to THF 2-22. Protection of the methanol and removal of 
the acetyl group gave a second pentenol (2-23) which gave rise to the core (2-24) of the 
natural product. Aplysiallene (2-4) was synthesized in 16 steps total in this report.
8
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Scheme 2.5 Total synthesis of aplysiallene by Wang and Pagenkopf 
 
 As the new water-soluble cobalt catalyst has only recently been developed, it has 
seen limited application in total synthesis. The Pagenkopf group has been interested in 
amphidinolide C and two separate fragments have been reported. The Co(nmp)2 was used 
in both cases to synthesize the THF portions of each fragment. The first was the synthesis 
of the C-18 - C-34 fragment in 2011.
9
 Epoxide 2-25 was opened with allylmagnesium 
bromide to generate the required pentenol 2-26 which was cyclized with Co(nmp)2 in 
excellent yield to THF 2-27. Fragment 2-28 was completed on gram scale and 
demonstrated the application of this catalyst in larger scale applications (Scheme 2.6). 
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Scheme 2.6 Synthesis of C-18 - C-34 of amphidinolide C 
 
 More recently, the methyl substituted THF of amphidinolide C and F was 
synthesized by the Pagenkopf group.
10
 The synthetic advantage of the catalyst was 
demonstrated here as pentenol 2-29 when treated with Co(modp)2 gave no THF 
formation, however when Co(nmp)2 was employed, THF 2-30 was obtained in 94% yield 
(Scheme 2.7). 
 
 
Scheme 2.7 Methyl-substituted THF synthesis of amphidinolide C and F 
 
 The oxidative cyclization to provide the trans-2,5-THF diastereomer exclusively 
has developed into a powerful reaction. It was proposed that key components of other 
natural products could be synthesized with this method. One such molecule was biselide 
A, a THF containing macrolide. 
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2.1.4 - Biselide A: Isolation, biological activity and previous syntheses of related 
natural products  
 The first members of this class of macrolides were the haterumalides, isolated in 
1999 from the Okinawan sponges, Ircinia and Lissoclinum sp.
11
 Additional members of 
this class of chlorinated macrolide, Biselides A and B were not isolated until 2004 from a 
different Okinawan sponge, Didemnidae sp.
12
 with the remainder of the family reported 
from the same species later in 2005.
13
 Not only have the haterumalides been isolated 
from these seas sponges, they have also been isolated from bacteria growing in soil.
14
 The 
biselide family of natural products (A (2-1), B (2-31), C (2-32), D (2-33), E (2-2)) and 
haterumalides NA (2-34) all have the trans-THF functionality and as such are interesting 
targets from a synthetic perspective (Figure 2.2). Key and potentially challenging 
structural features of these molecules include: a vinyl chloride, a skipped diene, 14-
membered macrocycle (for biselides A-D and haterumalide NA), and 2,3,5-trisubstituted 
THF. 
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Figure 2.2 Structure of biselides A-E and haterumalide NA 
 
 The majority of these macrolides do not show any significant biological activity, 
with the exception of biselide A (2-1), B (2-31) and haterumalide NA (2-34). 
Interestingly, when compared to the anticancer drug cisplatin, biselide A and 
haterumalides NA were more cytotoxic towards breast and lung cancer.
15
 Although these 
two natural products showed strong cytotoxicity towards cancer cell lines, only 
haterumalide NA demonstrated any significant cytotoxicity.
12
 Developing means to 
achieve the total synthesis of these targets could allow for the further application of these 
in biological studies. Although these compounds all have similar structural features, the 
majority of synthetic efforts towards this family have been directed towards haterumalide 
NA. 
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 In 2003, Kigoshi was the first to report on efforts towards haterumalide NA, with 
the C-15 epimer of haterumalide NA methyl ester being the first to succumb to synthesis 
(Scheme 2.8).
16
 Ether 2-35 was converted in 11 steps to THF 2-36 and taken on to vinyl 
chloride 2-38. With vinyl chloride 2-38 in hand, the key intermediate (2-39) was accessed 
in 5 steps by some protecting group swapping and conversion to bromo-acetate followed 
by oxidation. Reformatsky ring closure was used in this report to access macrocycle 2-40. 
Haterumalide NA methyl ester 2-42 was obtained after a deprotection and oxidation 
followed by Nozaki-Hiyama-Kishi with vinyl iodide 2-41.  
 
74 
 
 
 
Scheme 2.8 Kigoshi’s synthesis of C-15-epi-haterumalide NA methyl ester 
 
 Kigoshi reported two subsequent publications whereby the application of a 
Suzuki-Miyaura coupling with conversion to the chloride furnished vinyl chloride 2-38.
17
 
In addition to the works reported by Kigoshi, several other groups have also been 
interested in the haterumalides. For instance, in 2003, Snider reported the application of a 
Yamaguchi macrolactonization for ring closure in the second synthesis of the enantiomer 
of haterumalide NA methyl ester (2-42) (Scheme 2.9).
18
 The synthesis of the THF portion 
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started from diol (2-43) which converted into THF-methanol (2-44) in good overall yield. 
Dichloride (2-45) was obtained in four steps from 2-44 including diol protection, TBS 
deprotection, partial alkyne reduction and conversion to the terminal chloride. 
Macrolactonization substrate (2-46) was obtained by Stille coupling of 2-45 with vinyl tin 
2-47. Subsequent acetal opening, along with primary alcohol protection as the trityl ether 
followed by saponification revealed acid 2-48. Yamaguchi reaction gave macrocycle 2-
49 which was converted in a similar manner as Kigoshi’s end game in good yields to ent-
haterumalide NA methyl ester (2-50). 
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Scheme 2.9 Snider’s approach the ent-haterumalide methyl ester 
 
 A few years later, the first total synthesis of (-)-haterumalide NA (2-34) was 
accomplished by Hoye, by application of an intramolecular chloropalladation reaction for 
construction of the macrocycle (Scheme 2.10).
19
 An advanced stage intermediate (2-51) 
was treated with a Pd
II
 catalyst which underwent the chloropalladation reaction to 
macrocycle 2-52 in a nearly 1:1 isomeric ratio of the C-4 - C-5 double bond geometry 
(Z:E = 1:1.4). The acid side chain was attached through similar chemistry as the previous 
reported. 
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Scheme 2.10 First total synthesis of haterumalide NA by Hoye et al. 
 
 An initial addition of the palladium species to the terminal alkyne would place the 
palladium on the terminal carbon (2-53) which is now able to coordinate the alkene. 
Insertion of the alkyl halide would afford to give the proposed palladium intermediate 2-
54 which has been proposed to undergo β-elimination to generate the skipped diene end 
product (2-55) (Scheme 2.11).
20
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Scheme 2.11 Kaneda’s proposed chloropalladation mechanism 
 
 A more recent total synthesis of haterumalide NA (2-42) and NC (2-56) was 
reported by Borhan which used a chromium carbenoid for macrocycle closure (Scheme 
2.12).
21
 An advanced stage trichloro alkane 2-57 was combined with tri-substituted THF 
2-58 under Mitsunobu conditions to trityl ether 2-59 which after deprotection and 
oxidation afforded their key intermediate 2-60 for chromium ring closure. Treatment of 
2-60 with excess chromium(II) led to the correct diastereomer 2-61 of the macrocycle of 
haterumalide NC. At this point, two routes were undertaken to provide the two natural 
products. Under Barton deoxygenation conditions, a common intermediate (2-62) of 
haterumalide NA was synthesized giving rise to a formal synthesis of the aforementioned 
natural product. On the other hand, with the oxygen in tow, haterumalide NC (2-56) was 
successfully synthesized using similar protocols as previous reported. 
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Scheme 2.12 Borhan’s syntheses of haterumalide NC and NA 
 
 Excess chromium(II) initially adds twice into the trichloro methane unit. A 
subsequent syn-elimination would thus generate the desired chromium carbenoid and a 
chromium hydride species in the process.
22
 In Borhan’s case, the proximal aldehyde 
would allow nucleophilic attack by the carbenoid resulting in macrocycle formation. 
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 Roulland has reported the synthesis of haterumalide NA (2-34) which 
demonstrates the application of a palladium-catalyzed THF forming reaction and ring 
closure using the Yamaguchi macrolactonization as demonstrated by Kigoshi’s seminal 
synthesis of this family of molecules.
23
 Taking diol 2-63 in the presence of a 
palladium(II) catalyst underwent a Tsuji-Trost reaction affording trans-THF 2-64 in 
excellent yields and diastereoselectivity (Scheme 2.13). Initially inseparable, once 
derivatized to the benzoyl ester (2-65), the diastereomers could be separated. With THF 
2-66 in hand, the total synthesis of haterumalide NA (2-34) was accomplished by a 
Suzuki-Miyaura reaction and macrocycle formation by Yamaguchi reaction 
 
 
Scheme 2.13 Roulland’s approach to haterumalide NA 
 
 Subsequently, the Roulland group expanded on the application of palladium 
catalyzed THF formation towards several natural products including haterumalide NA (2-
34).
24
 This second report discloses the proposed origin of the high diastereoselectivity 
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observed in the THFs (Scheme 2.14). Under the reaction conditions, diol 2-66 would 
form the coordinated intermediate 2-67, which in turn would attack the π-allyl with 
formation of trans-THF 2-68. Formation of π-allyl intermediate would in turn liberate an 
acetoxy which Roulland invokes as a key interaction for the observed diastereoselectivity 
of the reaction.
24
  
 
 
Scheme 2.14 Origin of diastereoselectivity 
 
 Although the majority of synthetic efforts have been directed towards the 
haterumalides and more specifically, haterumalide NA, the biselide family has had two 
studies towards key components of their structures.  
 The application of ring closing metathesis (RCM) was demonstrated by Cossy as 
a facile method for the rapid access of the α,β-unsaturated lactone side chain of biselide E 
(2-33) (Scheme 2.15).
25
 Lactone 2-69 was opened up in two steps to afford ethyl ester 2-
70 which underwent a controlled reduction and Wittig olefination to vinyl iodide 2-71. 
The iodide was then treated with a palladium catalyst in a Stille coupling with subsequent 
reduction to diene 2-72. Acylation of the primary alcohol set up the substrate for RCM to 
the unsaturated lactone 2-73. This moiety was rapidly protected as it was reported to 
undergo rapid decomposition. Lactone 2-73 was converted to methyl acetal 2-74 which 
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undergoes elimination with SmI2 to the desired di-chloro alkene 2-75 subunit side chain 
of biselide E. 
 
  
Scheme 2.15 Cossy’s synthesis of biselide E side chain 
 
 More recently, Kigoshi reported on the progress towards biselide A (2-1) and B 
(2-31) with the synthesis of the core of these natural products (Scheme 2.16).
26
 The 
synthesis began from a common intermediate 2-76 of the syntheses of other family 
members which was converted to vinyl iodide 2-77 over two steps with the cis isomer of 
C-4 - C-5 being favored (Z:E = 3:1). Following reduction and deprotection revealed a 
substrate (2-78) that was set up for Stille coupling followed by dihydroxylation to 
generate desired diol 2-79. Conversion to isopropyl ester 2-80 gave all the carbon atoms 
83 
 
 
for the core of the molecule. Vinyl iodide 2-81 was carried forward to accomplish the 
synthesis of biselide E (2-33). Stille coupling with ethyl ester 2-82 afforded diene 2-83 
which was treated under acidic conditions to furnish the natural product. 
 
 
Scheme 2.16 Kigoshi’s work on the biselide family 
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 The presented reports on the progress and completed syntheses of the 
haterumalides and biselides all demonstrated very unique and powerful methods for ring 
closure to provide the macrocyclic structure of these natural products. Inspired by these 
reports and the recent development of a Cobalt catalyst for the oxidative formation of 
trans-THFs we sought to apply our catalyst towards the total synthesis of biselide A and 
E.  
 
2.2 - Results and discussion 
2.2.1 - Initial attempts at biselide E 
 The initial target for this project was to continue and complete the synthesis of 
biselide E (2-2). Prior work from a previous graduate student (Barbora Morra, PhD) was 
directed towards the total synthesis of biselide E (2-2).
27
 The original retrosynthesis 
proposed by Barbora Morra of Biselide E (2-2) could be broken down into protected THF 
2-82 and vinyl iodide 2-83. THF 2-82 would come from Suzuki-Miyaura coupling 
between THF (2-84) and dichloro-alkene 2-75 (Scheme 2.17). 
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Scheme 2.17 Retrosynthesis of biselide E 
 
 Barbora’s work ran into difficulties during the preparation of dichloro alkene 2-
75. A successful route to alcohol 2-86 was developed in her work. Conversion of 
propanediol to lactone 2-85 work in good overall yields and was subsequently converted 
to the more stable methyl acetal by reduction, methylation and removal of the silyl 
protecting group to reveal alcohol 2-86 (Scheme 2.18).
27
 Several attempts at oxidation to 
aldehyde 2-87 resulted in rapid decomposition as the methyl acetal was reported to be 
sensitive to acidic conditions.
25
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Scheme 2.18 Attempted synthesis of dichloro alkene fragment for biselide E 
 
 With unsuccessful oxidation attempts to access aldehyde 2-87, it was envisaged 
that formation of the dichloro alkene moiety at an early stage of the synthesis would 
solve the problems associated with decomposition (Scheme 2.19). With this plan, we set 
to develop conditions to the alkene fragment and using the work previously established 
by Barbora Morra to complete the total synthesis of biselide E. Beginning from 
propanediol, which was mono-protected as silyl ether 2-88 which underwent subsequent 
oxidation under Swern conditions to aldehyde 2-89 in good yield.  
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Scheme 2.19 Attempted early stage formation of a dichloro alkene 
 
 The generation of dichloro alkene 2-90 proved to be difficult as multiple attempts 
led to decomposition of the alcohol. A one pot procedure that would convert aldehyde 2-
89 to tri-chloro alkane 2-91 with subsequent elimination gave an inseparable black 
mixture with no recoverable aldehyde. A two step protocol was also investigated similar 
to the one step procedure; however trichloro alkane intermediate (2-91) would be isolated 
prior to subjecting it to the elimination conditions. As with the one pot method, there was 
no observation of the desired alkene 2-90. Formation of a phosphonium ylide was 
attempted with carbon tetrachloride and PPh3, and although 
1
H NMR spectra showed 
promising peaks, the product yield was low and this route was abandoned due to it not 
being practical. The low yield is likely the result of sluggish formation of the ylide 
combined with decomposition of aldehyde 2-89.  
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 Without a successful way to access the dichloro alkene subunit and avoid the 
previously observed decomposition, work was directed towards the synthesis of biselide 
A (2-2). 
 
2.2.2 - Progress Towards Biselide A 
2.2.2.1 - Ring Closing Metathesis and Relay Ring Closing Metathesis 
 The biggest challenge associated with accomplishing the total synthesis of 
biselide A (2-2) was developing a new method for formation of the macrocycle. Ring 
closing metathesis has been employed in a wide range of total syntheses of complex 
natural products and serves as a facile means to access macrocycles which contain a 
carbon-carbon double bond in the ring system.
28
 In general a large number of ring closing 
metathesis reactions used a ruthenium carbenoid catalyst such as the ones reported by 
Grubbs’ (2-92 and 2-93) as well as Schrock’s molybdenum catalyst (2-94) (Figure 
2.3).
28a
 
 
 
Figure 2.3 Examples of ring closing metathesis catalyst by Grubbs’ and Schrock 
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 Ring closing metathesis goes through a catalytic cycle which joins to proximal 
olefins together with regeneration of a ruthenium carbenoid active catalyst (Scheme 
2.20).
29
 In general a cyclic system bearing two olefins (2-95) would be closed to olefin 2-
96 after treatment with a catalyst. The metal carbenoid (2-97) would undergo a [2+2] 
cycloaddition with one of the olefins affording metallocyclobutane 2-98 which loses 
ethylene and generates a second metallocarbenoid 2-99. A second [2+2] with the 
proximal olefin would give a different metallocyclobutane 2-100 which undergoes a retro 
[2+2] give the ring system (2-96) and the active metallocarbenoid which continues in the 
catalytic cycle.
29
 
 
 
Scheme 2.20 Catalytic cycle for ring closing metathesis 
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 The epothilones were synthesized in 1997 by Nicolaou demonstrating the 
applicability of ring closing metathesis in total synthesis (Scheme 2.21).
30
 In this report, 
advanced stage intermediate 2-101 was treated with Grubbs’ GI catalyst to obtain 
macrocycle 2-102 which was subsequently epoxidized and epothilone A (2-103) was 
obtained. 
 
 
Scheme 2.21 Nicolaou’s synthesis of the epothilones 
 
 A second example that deployed a ring closing metathesis strategy was the 
synthesis of amphidinolide A by the Maleczka research group (Scheme 2.22).
31
 
Treatment of a poly-olefin substrate (2-104) with Grubbs’ GII catalyst provided the 
macrocyclic core of the natural product (2-105) which, in three additional steps, provided 
access to amphidinolide A (2-106). 
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Scheme 2.22 Ring closing metathesis strategy by Maleczka for amphidinolide A 
 
 The concept of relay ring closing metathesis was developed as a means to 
generate an active metal carbenoid which could facilitate the ring closing event between 
two sterically hindered olefins. In 2004, the Hoye research group developed this 
methodology for the facile generation of macrocycle which were otherwise unreactive 
towards standard ring closing metathesis reactions.
32
 A selected example from Hoye’s 
relay ring closing strategy showed that polyene ether 2-107 could undergo the relay 
strategy to generate a macrocyclic product 2-108 (Scheme 2.23). The reaction proceeds 
through an initial [2+2] of the terminal olefin with Grubbs’ GII catalyst to carbenoid 2-
109 which undergoes a ring closing event with the internal olefin. After cycloreversion 
generated the internal active ruthenium carbenoid 2-110, subsequent ring closing 
metathesis occurred and macrocycle 2-108 was obtained.  
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Scheme 2.23 Hoye’s relay ring closing metathesis 
 
 Relay ring closing metathesis has been demonstrated in the total synthesis of 
oximidine III by the Porco research group (Scheme 2.24).
33
 Initially, standard ring 
closing metathesis was attempted for formation of the core of the molecule, however after 
low yields were obtained of the desired target, relay ring closing metathesis was able to 
successfully generate the desired macrocycle. Relay substrate 2-111 was subjected to 
Grubbs’ GII giving ruthenium carbenoid 2-112 which underwent a [2+2] followed by 
cycloreversion with the proximal internal olefin liberating cyclopentene along with the 
terminal ruthenium species 2-113. Finally, desired olefin 2-114 was revealed after ring 
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closing metathesis with oximidine III (2-115) being synthesized in an additional four 
steps from the macrocycle. 
 
 
Scheme 2.24 Relay ring closing metathesis in total synthesis of oximidine III by Porco 
 
 A more relevant example to this thesis is Hoye’s attempts at utilizing his relay 
strategy for the total synthesis of haterumalide NA.
19
 In the presence of Grubbs’ GII 
catalyst, the attempted relay protocol of THF 2-116 to macrocycle 2-117 was 
unsuccessful and under the reaction conditions a truncated product was obtained 2-118 
(Scheme 2.25). Although the terminal olefin of the tether engaged in the formation of the 
ruthenium carbenoid and underwent the transfer to the internal olefin, the presence of the 
THF moiety did not allow the ring closing to occur which would lead to the desired 
product.
19
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Scheme 2.25 Hoye’s attempted relay ring closing metathesis to haterumalide NA 
 
 Hoye suggests that the presence of the rigid THF functionality in the molecule 
dissuades the substrate from undergoing the second metathesis event. This same 
suggestion can also be applied to biselide A, as the olefin between C-4 and C-5 is even 
further sterically hindered by the two allylic oxygen atoms. With this in mind, we set out 
to synthesize biselide A by employing a tethering strategy which would increase the 
overall ring and facilitate ring closure.
19
 
 This concept has seen application with silicon-based tethers which are easily 
removed.
34
 For instance, in 2006 Miller demonstrated this application in total synthesis 
by using a silicon-tether in the synthesis of streptazolin (2-119) (Scheme 2.20).
35
 
Cyclopentene 2-120 was converted to silyl ether 2-121 which underwent RCM followed 
by protodesilylation to remove the tether to reveal alcohol 2-122 and eventually 
synthesized streptazolin. 
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Scheme 2.26 Miller’s silicon-tether based synthesis of streptazolin 
 
2.2.2.2 - Retrosynthesis 
 Using this general concept however with the application of an ester tether our 
retrosynthesis of biselide A (2-29) is presented in Scheme 2.27 following similar strategy 
as previous outlined in Barbora Morra’s PhD thesis27 however with the addition of 
tethering strategy for macrocycle synthesis. Biselide A would arise from a Nozaki-
Hiyama-Kishi reaction between THF 2-123 and vinyl iodide 2-124 as reported in 
syntheses of the haterumalides.
16,17,18,19,21,23
 THF 2-123 would arise from esterification of 
THF 2-126 and tether incorporated ester 2-127 (tether depicted as A-B). THF 2-125 is the 
result of the key oxidative cyclization of diol 2-127 using our water soluble Co(nmp)2 
catalyst. It should be noted that THF-diol 2-126 was previously synthesized by Barbora 
Morra and well as progress towards the acid fragment 2-167,
27
 however all material had 
been used up the synthesis had to be repeated from the beginning. The author’s 
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contribution was the studies towards tether lengths as well as the completion of the tether 
incorporated acid. 
 
 
Scheme 2.27 Tether strategy to access biselide A 
 
2.2.2.2 - Synthesis of 2,3,5-trisubstituted THF 
 To begin, Co(nmp)2 was synthesized according to literature procedure (Scheme 
2.22).
5
 Piperazine 2-128 was treated with Et3N followed by ethyl oxalyl chloride 2-129 to 
give acylated piperidine 2-130. Claisen condensation with pinacolone afforded the nmp 
ligand 2-131 after acidic work-up. The catalyst 2-132 was prepared by complexation with 
a cobalt (2-ethylhexanoate)2 in good yield. 
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Scheme 2.28 Synthesis of Co(nmp)2 
 
 In order to obtain the correct diastereomer of the requisite diol (2-127), the 
application of an asymmetric aldol was decided to be the easiest method for obtaining 
high dr of the product. Evans’ chiral oxazolidinone auxiliary was decided on after several 
others were previously screened with limited success.
27
 
 Evans’ auxiliary was reported in 1981 to afford syn aldol products with excellent 
diastereoselectivity.
36
 The high selectivity for the syn aldol product is presented in 
Scheme 2.23. Treatment of oxazolidinone 2-133 with Bu2BOTf generates exclusively the 
Z-enolate, which in turn would react with an aldehyde (2-134) to generate syn aldol 
product 2-135 (Scheme 2.23). 
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Scheme 2.29 Evans’ chiral auxiliary for asymmetric aldol reactions 
 
 Although there are other potential transition states, the two presented in Scheme 
2.23 are those whose dipoles are anti-parallel. Enolate 2-136 however, is favored as the 
limited steric interactions (compare to 2-137) lower the resulting energy and lead to the 
observed Evans’ syn aldol product with complete diastereoselectivity for oxazolidinone 
2-135 compared to the other syn diastereomer 2-138.
36
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 The synthesis of the auxiliary was carried out according to literature whereby 
reduction of (S)-phenylalanine 2-139 afforded amino alcohol 2-140. Oxazolidinone 2-141 
was obtained by treatment with diethyl carbonate in the presence of K2CO3. Acylation of 
the auxiliary proceeded smoothly to chlorinated auxiliary 2-142 (Scheme 2.24).
37
  
 
 
Scheme 2.30 Preparation of chlorinated oxazolidinone 
  
 A repetition of the previously reported work by Barbora Morra
27
 is presented in 
Scheme 2.31 - 2.33. As no starting was provided, the yields presented are those obtained 
by the author.  
 Aldehyde 2-143 was prepared in two steps from alcohol 2-144 and treated under 
Evans’ aldol reaction conditions. Oxazolidinone 2-142 was treated with Bu2BOTf, 
DIPEA and aldehyde 2-143 to afford the corresponding syn aldol product 2-145 in good 
yield and excellent diastereoselectivity (dr > 20:1) (Scheme 2.31). Removal of the 
temporary chlorine was accomplished by treating the aldol product with Zn powder and 
NH4Cl to reveal alcohol 2-146 in good yield. 
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Scheme 2.31 Formation of a TMS-alkyne by Evans’ aldol 
 
 With acylated oxazolidinone successfully synthesized as the required 
diastereomer, the formation of diol 2-127 as a precursor for oxidative cyclization was 
attempted (Scheme 2.32). Formation of Weinreb amide 2-147 worked in high yield and 
was subsequently treated with vinylmagnesium bromide. The addition gave low yields of 
the desired β-hydroxy ketone; however 2-148 was continued through the synthesis. Diol 
2-127 was obtained via Prasad reduction
38
 giving exclusively the syn-diol set up for 
cyclization. 
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Scheme 2.32 Formation of cyclization precursor diol 2-127 
 
 At this point, with diol 2-127 in hand, the substrate was prepared for cyclization 
to THF 2-126 using Co(nmp)2 (2-132) for oxidative cyclization (Scheme 2.33). 
Treatment of diol 2-127 with our cobalt catalyst (2-132) gave the cyclized target 2-126. 
However, as limited amount of material remained at this point, no further derivatization 
of diol 2-126 was able to be performed. 
 
 
Scheme 2.33 Co-catalyzed oxidative cyclization 
 
2.2.2.3 - Synthesis of Tether Incorporated Acid 
 The incorporation of the tethered portion of the molecular was the contribution of 
the author towards biselide A. Before embarking on the synthesis of the two key 
substrates, we had to determine the appropriate length of tether. As we envisioned our 
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tether both having an ester connected through carbon atoms to a carboxylic acid end, we 
set out to investigate the affects of the differing lengths of carbon change of the 
minimized energy of the tether incorporated macrocycle.  
 Our idea of introducing a tether into the acid fragment from our retrosynthesis 
was thought to increase the flexibility of the ring and allow the substrate to undergo the 
RCM reaction to generate the skipped diene portion of the macrocycle. Upon successful 
RCM macrocycle 2-149 would be generated and subsequent removal of the tether would 
yield a substrate capable of undergoing an esterification reaction to complete the lactone. 
Treating macrocycle 2-149 either in reducing conditions or by saponification would give 
esterification precursor 2-150 (Scheme 2.34). 
 
 
Scheme 2.34 Incorporation and tether excision 
 
 Using molecular mechanics and examining the minimized energies of two 
compounds we determined the desired tether length that would be used for the synthesis 
of biselide A. The concept is shown in figure 2.4 with 2-151 having the tether portion 
incorporated directly into the macrocycle and 1-152 having the same atoms present in the 
tether on the acid side chain of the molecule. If the simulated minimized energy of 2-151 
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was lower than that of 2-152, the RCM should have chance to proceed with generation of 
the C-4 - C-5 olefin of the final natural product (Figure 2.4). 
 
 
Figure 2.4 Minimized energy requirements for tether incorporated RCM 
 
 The application of molecular mechanics of different tether lengths was next 
investigated (Table 2.1). Addition of extra carbon atoms (A-B) gave varying results on 
the minimized energies of 2-151 and 2-152. 
 
Table 2.1 Affect of different tether lengths on the minimized energies 
Entry A-B 
energy of 2-151 
(kJ/mol) 
energy of 2-152 
(kJ/mol) 
lower energy 
compound 
1  154.7016 164.9893 2-151 
2  65.9665 -2.5288 2-152 
3  29.4792 44.2448 2-151 
4  102.8781 29.7951 2-152 
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 A very short tether length did lead to a decrease in energy when the tether was 
inserted into the macrocycle (Table 2.1, entry 1). As the tether length was increased 
further a decrease in the minimized energy was observed however with two carbon atoms 
in the tether the energy of 2-151 was higher than that of 2-152. When a third carbon atom 
was added into the tether a significant decreased in the simulated energy was observed 
between 2-151 and 2-152 (Table 2.1, entry 3). Further increase of the number of carbon 
atoms showed a large increase in the simulated energy of 2-151 when compared to 2-152 
(entry 4). 
 With the simulated results presented in table 2.1, a tether with three carbons 
between a hydroxyl and a carboxylic acid was decided on as the target molecule (2-153) 
to utilize as the tether (Scheme 2.35). The RCM of the precursor 2-154 would then 
generate an enlarged ring system 2-155 bearing a 19-membered macrocyclic core. 
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Scheme 2.35 Planned ring closing metathesis of 2-154 to macrocycle 2-155 
  
 The route towards the synthesis of acid 2-153 began from methyl acrylate (1-56) 
which was treated under Bayliss-Hillman reaction condition to afford alcohol 2-157 
which was protected as silyl ether 2-158 (Scheme 2.36). Subsequent reduction in the 
presence of DIBAL provided allyl alcohol 2-159, Swern oxidation gave aldehyde 2-160 
which underwent an aldol reaction with either ethyl acetate or tert-butyl acetate to give 
ester 2-161 or 2-162 respectively. 
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Scheme 2.36 Progress towards acid fragment 
 
 Initial attempts at ester saponification began without protection of the secondary 
alcohol in hopes of limiting some additional protection and deprotection steps (Scheme 
2.37). Difficulties were met when the secondary alcohol was not protected because 
saponification of ethyl ester 2-161 under standard conditions did not afford the desired 
acid (2-163). The 
1
H NMR spectra showed no peaks that could be attributed to the TBS 
group likely as the silyl ether had been deprotected in this instance. Changing the 
concentration of the base or increasing or decreasing the amount added all led to similar 
results. 
 
 
Scheme 2.37 Attempted saponification with unprotected hydroxyl group 
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 Along the same idea utilizing different conditions for ester saponification, the 
tert-butyl ester (2-162) was treated with TMSOTf and DIPEA or TMSOTf and Et3N for 
the formation of acid 2-163 (Scheme 2.38). As with the ethyl ester, treating 2-162 under 
the above conditions led to rapid decomposition of the starting material and no formation 
of the desired acid. 
 
 
Scheme 2.38 Removal of tert-butyl ester 
 
 As our plan involved formation of β-keto-acid 2-164 which would be 
subsequently reduced as in Hoye’s total synthesis,19 oxidation of the allylic alcohol was 
investigated followed by removal of tert-butyl ester. To that end, oxidation under Parikh-
Doering conditions provided good yield of ketone 2-165 (Scheme 2.39). Attempted 
removal of the tert-butyl group proceeded quickly in the presence of TFA, and was very 
sluggish when TMSOTf and 2,6-lutidine were used. Acid 2-164 was not obtained after 
stopping the reaction with TFA as many additional peaks were observed in the 
1
H NMR 
spectra which did not correspond to the product. 
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Scheme 2.39 Attempted formation of acid 2-164 
 
 As decomposition was becoming a problem with the substrates tested, it was 
decided that keeping the secondary hydroxyl group protected would alleviate competitive 
deprotonation of the acidic proton and the resulting decomposition pathway. Ester 2-161 
was protected as the bis-TBS protected ester 2-166 in good yield (Scheme 2.40). 
Following hydrolysis with LiOH, acid 2-167 was obtained, a substrate that was set up to 
undergo esterification with protected diol 2-168 or 2-169. 
 
 
Scheme 2.40 Preparation of Mitsunobu partners 
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 Attempted Mitsunobu reaction of acid 2-167 with alcohol 2-169 did not proceed 
with a slight excess of PPh3 and DIAD however upon treatment with a large excess, ester 
2-171 was formed (Scheme 2.41). Although in low yields, a compound with all the atoms 
present for the tether portion was obtained. Deprotection of the PMB-ether with DDQ 
proceeded in good yields to alcohol 2-172. Subsequent oxidation with TEMPO and 
bis(acetoxy)iodobenzene gave target acid 2-173 in high yields. 
 
 
Scheme 2.41 Completion of C-1 to C-4 ester tethered acid 
 
2.3 - Future work 
2.3.1 - Formation of skipped diene system 
 The next steps for the completion of biselide A will involve the successful 
formation of the core of the molecule. The planned route would start from bis-protected 
THF 2-174 which an analogous compound has been previously shown to undergo TMS 
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deprotection to alkyne 2-175. Chloropalladation would then afford the skipped diene 2-
176 between C-4 and C-8 and provide access to the requisite terminal alkene which 
would be subjected to RCM (Scheme 2.42). 
 
 
Scheme 2.42 Planned route to RCM coupling partner 
 
2.3.2 - Formation of RCM precursor 
 With acid 2-173 being successfully synthesized, esterification with mono-
protected THF 2-176 would give a substrate (2-154) set-up to undergo the key RCM 
reaction (Scheme 2.35). 
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Scheme 2.43 RCM precursor synthesis 
 
 Formation of 2-150 (see Scheme 2.34) would then be subjected to 
macrolactonization to the core of biselide A (2-177). Biselide A would be completed by 
employing the Nozaki-Hiyama-Kishi reaction (Scheme 2.44). 
 
 
Scheme 2.44 Completion of the total synthesis 
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2.4 - Summary 
 The application of the Co(nmp)2 catalyst was shown to provide the THF portion 
of the natural product in good yield which was consistent with previously reported work 
by Barbora Morra. The author’s contribution to this project was the development of an 
appropriate tether length in order to overcome the imposed kinetic barrier by the THF 
ring and its incorporation into an appropriately functionalized acid fragment. It was 
modelled that with the addition of a five atom tether this kinetic barrier could be 
overcome allowing subsequent RCM to occur to generate the diene system in the 
macrocycle backbone. Although the total synthesis was not accomplished, the planned 
synthesis would provide an elegant means to access the molecule’s core and subsequently 
develop its first synthesis. 
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2.5 - Experimental 
2.5.1 - General considerations 
 General considerations are the same as provided in chapter 1. 
2.5.2 - Experimental procedures 
 
 
Ethyl 2-(4-methylpiperazin-1-yl)-2-oxoacetate (2-103) 
A solution of N-methylpiperazine (19.0 mL, 171 mmol) and Et3N (23.8 mL, 171 mmol) 
in CH2Cl2 (171 mL) at 0 °C was added ethyl oxalyl chloride (19.1 mL, 171 mmol) 
dropwise. The solution was warmed to RT and stirred for 16 h. The reaction was 
quenched by the addition of a half saturated solution of NaHCO3 (aq) and extracted with 
CH2Cl2 (3 x 100 mL). The combined organic extracts were washed with brine, dried over 
MgSO4, filtered through a pad of Celite and concentrated under reduced pressure to 
afford a viscous orange oil (34 g, 98%) which was used without further purification. 
1
H 
NMR (CDCl3, 400 MHz) δ 4.27 - 4.21 (m, 2H), 3.56 - 3.54 (m, 2H), 3.37 - 3.34 (m, 2H), 
2.35 - 2.33 (m, 4H), 2.22 (s, 3H), 1.30 - 1.25 (m, 3H); 
13
C NMR (CDCl3, 101 MHz) δ 
162.5, 159.9, 61.9, 54.6, 53.9, 45.8, 41.0, 13.8.  
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(Z)-2-Hydroxy-5,5-dimethyl-1-(4-methylpiperazin-1-yl)hex-2-ene-1,4-dione (2-104) 
A solution of glyoxylate 2-103 (4.0 g, 20 mmol) and pinacolone (2.50 mL, 20 mmol) in 
THF (120 mL) at 0 °C was added a solution of tBuOK (4.53 g, 40 mmol) in THF (200 
mL) via cannula. The reaction was warmed to RT and stirred overnight. To the mixture 
was added a 1N AcOH in CH2Cl2 (40 mL) and stirred 0.5 h then filtered through Celite 
and concentrated under reduced pressure to afford an orange oil (3.71 g, 73%) which was 
used without further purification. 
1
H NMR (CDCl3, 400 MHz) δ 5.96 (s, 1H), 3.66 - 3.65 
(m, 2H), 3.60 - 3.58 (m, 2H), 2.46 - 2.42 (m, 4H), 2.30 (s, 3H), 1.18 (s, 9H); 
13
C NMR 
(CDCl3, 101 MHz) δ 200.9, 185.3, 163.9, 95.3, 55.1, 54.3, 45.8, 41.6, 27.2. 
 
 
Co(nmp)2 (2-105) 
A solution of nmp (2-104) (2.62 g, 10.3 mmol) in benzene (50 mL) was added 
Co(ethylhexanoate) (65% in mineral spirits, 2.73 mL, 5.15 mmol) and stirred for 12 min. 
H2O added (0.93 mL) and the reaction stirred 16 h. Hexanes (200 mL) was added and the 
solids were separated by centrifugation. The brown solid was titurated with hexanes and 
concentrated under reduced pressure to afford Co(nmp)2 (2.73 g, 94%) as a tan solid. 
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(S)-4-Benzyl-3-(2-chloroacetyl)oxazolidin-2-one (2-115) 
A solution of oxazolidinone 2-114 (2.31 g, 13 mmol) in THF (220 mL) cooled to -78 °C 
was added BuLi (2.31 M in hexanes, 5.63 mL, 13 mmol) warmed to RT and stirred 2.5 h. 
The solution was cooled to -78 °C and added chloroacetyl chloride (1.14 mL, 14.3 mmol) 
stirred for 15 min then for 30 min at RT. The reaction was quenched by the addition of a 
solution of half saturated NH4Cl (aq) (50 mL) and extracted with EtOAc (3 x 20 mL). 
The combined organic extracts were washed with brine, dried over MgSO4, filtered 
through a pad of Celite and concentrated under reduced pressure. The crude reaction 
mixture was purified by flash column chromatography to afford the title compound as a 
white solid (2.90 g, 88%). Rf 0.47 (7:3 hexanes/EtOAc); 
1
H NMR (CDCl3, 600 MHz) δ 
7.35-7.33 (m, 2H), 7.30-7.27 (m, 1H), 7.20 (d, J = 7.0 Hz, 2H), 4.74 (s, 2H), 4.72-4.68 
(m, 1H), 4.30-4.27 (m, 1H), 4.26-4.24 (m, 1H), 3.34 (dd, J = 13.5, 3.5 Hz, 1H), 2.81 (dd, 
J = 13.5, 9.4 Hz, 1H); 
13
C NMR (CDCl3, 101 MHz) δ 166.1, 153.2, 134.7, 129.4, 129.1, 
127.6, 67.0, 55.4, 43.8, 37.6. 
 
 
5-(Trimethylsilyl)pent-4-yn-1-ol (2-116a) 
A solution of 4-pentyn-1-ol (2.22 mL, 24 mmol) in THF (50 mL) at -78 °C was added 
BuLi (2.31 M in hexanes, 23 mL, 53 mmol) and stirred for 1 h. Added TMSCl (6.7 mL, 
53 mmol), warmed to RT, added 1M HCl (30 mL), stir an additional 30 min and extract 
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with EtOAc (3 x 15 mL). The combined organic extracts were dried over MgSO4, filtered 
through a pad of Celite and concentrated under reduced pressure. The crude reaction 
mixture was purified by column chromatography to afford the title compound as a clear 
colorless oil (3.42 g, 92%). Rf 0.43 (3:2 hexanes/EtOAc); 
1
H NMR (CDCl3, 600 MHz) δ 
3.77 - 3.74 (m, 2H), 2.34 (t, J = 7.0 Hz, 2H), 1.76 (dt, J = 6.4 Hz, 2H), 1.55 (br s, 1H), 
0.14 (s, 9H); 
13
C NMR (CDCl3, 150 MHz) δ 106.6, 85.2, 61.7, 31.1, 16.4, 0.0. 
 
 
5-(Trimethylsilyl)pent-5-ynal (2-117) 
A solution of oxalyl chloride (1.30 mL, 15.1 mmol) in CH2Cl2 (30 mL) at -78 °C was 
added a solution of DMSO (1.43 mL, 20.1 mmol) in CH2Cl (15 mL) dropwise and stirred 
for an additional 30 min. Alcohol 2-116a in CH2Cl2 (15 mL) was added over 15 min and 
stirred 1 h. To the mixture was added Et3N (7.0 mL, 50.2 mmol) stirred for 15 min and 
allowed to warm to RT. The reaction was quenched by the addition of a half saturated 
solution of NH4Cl (aq) and extracted with CH2Cl2 (3 x 10 mL). The organic extracts were 
washed with brine, dried over MgSO4, filtered through a pad of Celite and concentrated 
under reduced pressure. The crude reaction mixture was purified by flash column 
chromatography to afford the title compound as a yellow oil (1.45 g, 94%). Rf 0.45 (9:1 
hexanes/EtOAc); 
1
H NMR (CDCl3, 400 MHz) δ 9.78 (s, 1H), 2.66 (t, J = 7.0 Hz, 2H), 
2.54 (t, J = 7.6 Hz, 2H), 0.13 (s, 9H); 
13
C NMR (CDCl3, 101 MHz) δ 200.3, 104.7, 85.7, 
42.5, 13.1, 0.0. 
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(S)-4-Benzyl-3-((2S,3R)-2-chloro-3-hydroxy-7-(trimethylsilyl)hept-6-
ynoyl)oxazolidin-2-one (2-118) 
A solution of oxazolidinone 2-115 (844 mg, 3.33 mmol) in CH2Cl2 (11 mL) cooled to -78 
°C was added iPr2NEt (780 μL, 4.44 mmol) followed by Bu2BOTf (1.0 M in CH2Cl2, 
3.99 mL, 3.99 mmol) and stirred for 1.5 h at RT. The reaction was cooled to -78 °C and 
added a solution of aldehyde 2-117 (342 mg, 2.22 mmol) in CH2Cl2 (2 mL) dropwise 
stirred for 30 min and 2 h at RT. The reaction was quenched by addition of 1.0 M 
NaHSO4 (4 mL) concentrated under reduced pressure and the slurry was dissolved in 
MeOH (25 mL). After cooling to 0 °C, 30% H2O2 (2 mL) was added and stirred 1 h. H2O 
(15 mL) and EtOAc (15 mL) added and the aqueous layer was extracted with EtOAc (3 x 
15 mL). The combined organics were washed with brine, dried over MgSO4, filtered 
through a pad of Celite and concentrated under reduced pressure. The crude reaction 
mixture was purified by flash column chromatography to afford the title compound as a 
light yellow oil (671 mg, 74%). Rf 0.49 (7:1 hexanes/EtOAc); 
1
H NMR (CDCl3, 600 
MHz) δ 7.33-7.30 (m, 2H), 7.27-7.25 (m, 1H), 7.20 (d, J = 7.0 Hz, 2H), 5.66 (d, J = 2.9 
Hz, 1H), 4.73-4.69 (m, 1H), 4.26-4.20 (m, 3H), 3.01-2.99 (m, 1H), 2.82 (dd, J = 13.5, 9.4 
Hz, 1H), 2.45-2.35 (m, 2H), 1.91-1.85 (m, 1H), 1.82-1.76 (m, 1H), 0.12 (s, 9H); 
13
C 
NMR (CDCl3, 150 MHz) δ 168.2, 152.5, 134.6, 129.4, 129.0, 127.5, 105.8, 85.5, 70.2, 
66.5, 59.4, 55.4, 37.2, 32.7, 16.2, 0.0; HRMS [m/z+H
+
] 408.0197 (calcd for 
C20H26ClNO4Si, 407.1320). 
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(S)-4-Benzyl-3-((R)-3-hydroxy-7-(trimethylsilyl)hept-6-ynoyl)oxazolidin-2-one  
(2-119) 
A solution of oxazolidinone 2-118 (370 mg, 0.91 mmol) in MeOH (9 mL) was added Zn 
powder (237 mg, 3.63 mmol) and NH4Cl (195 mg, 3.63 mmol). After 5 min of stirring 
the reaction was filtered through a pad of Celite and washed with MeOH (10 mL). After 
removal of volatiles, the crude reaction mixture was purified by flash column 
chromatography to afford the title compound as a light yellow oil (320 mg, 94%). Rf 0.29 
(3:1 hexanes/EtOAc); 
1
H NMR (CDCl3, 600 MHz) δ 7.33-7.31 (m, 2H), 7.27-7.25 (m, 
1H), 7.19 (d, J = 7.6 Hz, 2H), 4.69-4.67 (m, 1H), 4.24-4.16 (m, 3H), 3.26 (d, J = 13.5 Hz, 
1H), 3.09-3.05 (m, 3H), 2.79 (dd, J = 13.5, 9.4 Hz, 1H), 2.40 (dd, J = 7.0 Hz, 2H), 1.80-
1.69 (m, 2H), 0.13 (s, 9H); 
13
C NMR (CDCl3, 150 MHz) δ 172.3, 153.3, 134.9, 129.3, 
128.9, 127.3, 106.5, 66.6, 66.2, 54.9, 42.5, 37.7, 35.2, 16.2, 0.02; HRMS m/z 373.1719 
(calcd for C20H27NO4Si, 373.1709). 
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(R)-3-Hydroxy-N-methoxy-N-methyl-7-(trimethylsilyl)hept-6-ynamide (2-120) 
A solution of N,O-dimethylhydroxylamine hydrochloride (299 mg, 2.35 mmol) in THF (8 
mL) at 0 °C was added Me3Al (2.0 M in hexanes, 1.7 mL, 2.35 mmol) and stirred for 30 
min then 20 min at RT. The mixture was cooled to -15 °C and added a solution of 
oxazolidinone 2-119 (292 mg, 0.78 mmol) in THF (5 mL) dropwise and stirred for 4 h at 
0 °C. The reaction was quenched by the addition of 0.50 M HCl (16 mL) and extracted 
with EtOAc (3 x 10 mL). The combined organic extracts were washed with brine, dried 
over Mg(SO4), filtered through a pad of Celite and concentrated under reduced pressure. 
The crude reaction mixture was purified by flash column chromatography to afford the 
title compound as a yellow oil (180 mg, 90%). Rf  0.29 (3:2 hexanes/EtOAc); 
1
H NMR 
(CDCl3, 600 MHz) δ 4.14 - 4.10 (m, 1H), 3.80 (d, J = 2.9 Hz, 1H), 3.68 (s, 3H), 3.19 (s, 
3H), 2.68 (d, J = 16.4 Hz, 1H), 2.48 (dd, J = 17.0, 9.4 Hz, 1H), 2.44 - 2.35 (m, 2H), 1.78 
- 1.72 (m, 1H), 1.69 - 1.64 (m, 1H, 0.13 (s, 9H); 
13
C NMR (CDCl3, 101 MHz) δ 173.5, 
106.8, 84.7, 66.8, 61.2, 38.0, 35.2, 31.8, 16.2, 0.09; HRMS m/z 257.1452 (calcd for 
C12H23NO3Si, 257.1447). 
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(R)-5-Hydroxy-9-(trimethylsilyl)non-1-en-8-yn-3-one (2-121) 
A solution of Weinreb amide 2-120 (151 mg, 0.58 mmol) in THF (6 mL) at -40 °C was 
added vinylmagnesium bromide (1.0 M in THF, 1.74 mL, 1.74 mmol) dropwise. The 
mixture was stirred at 0 °C for 5 h, quenched with the addition of a half saturated solution 
of NH4Cl (aq), and extracted with EtOAc (3 x 10 mL). The combined organic extracts 
were washed with brine, dried over MgSO4, filtered through a pad of Celite and 
concentrated under reduced pressure. The crude reaction mixture was purified by flash 
column chromatography to provide the title compound as a yellow oil (61.1 mg, 48%). Rf 
0.66 (3:2 hexanes/EtOAc); 
1
H NMR (CDCl3, 600 MHz) δ 6.35 (dd, J = 17.6, 10.6 Hz, 
1H), 6.35 (d, J = 16.4 Hz, 1H), 5.90 (d, J = 11.7 Hz, 1H), 4.24 - 4.19 (m, 1H), 3.12 (d, J 
= 3.5 Hz, 1H), 2.82 (dd, J = 17.6, 2.9 Hz, 1H), 2.72 (dd, J = 17.6, 8.8 Hz, 1H), 2.41 - 2.36 
(m, 2H), 1.76 - 1.70 (d, 1H), 1.68 - 1.63 (m, 1H), 0.13 (s, 9H); 
13
C NMR (CDCl3, 150 
MHz) δ 200.9, 136.7, 129.2, 106.7, 85.1, 66.7, 45.6, 35.0, 16.2, 0.1; HRMS [m/z+H+] 
225.1305 (calcd for C12H20O2Si, 224.1233). 
 
 
(3R,5R)-9-(Trimethylsilyl)non-1-en-8-yne-3,5-diol (2-100) 
A solution of ketone 2-121 (104 mg, 0.46 mmol) in THF (4 mL) and MeOH (1 mL) 
cooled to -78 °C was added Et2BOMe (1.0 M in THF, 510 μL, 0.51 mmol) and stirred 1 h 
at -20 °C. After cooling to -78 °C, NaBH4 (19.3 mg, 0.51 mmol) was added portionwise. 
121 
 
 
Stirring was continued for 3 h, quenched with the addition of a half saturated solution of 
NaHCO3 (aq), warmed to RT and extracted with EtOAc (3 x 10 mL). The combined 
organics were washed with brine, dried over MgSO4, filtered through a pad of Celite and 
concentrated under reduced pressure. The crude reaction mixture was purified by flash 
column chromatography to afford a white solid (51.3 mg, 49%). Rf 0.41 (7:3 
hexanes/EtOAc); 
1
H NMR (CDCl3, 600 MHz) δ 5.84 (ddd, J = 17.2, 10.7, 6.2 Hz, 1H), 
5.23 (d, J = 17.6, Hz, 1H), 5.08 (d, J = 10.6 Hz, 1H), 4.37 - 4.35 (m, 1H), 3.99 - 3.97 (m, 
1H), 2.33 (dd, J = 7.0 Hz, 2H), 1.70 - 1.57 (m, 4H), 0.12 (s, 9H); 
13
C NMR (CDCl3, 150 
MHz) δ 140.6, 114.5, 106.8, 85.3, 73.5, 71.3, 42.7, 36.2, 16.1, 0.0. 
 
 
(2R,3R,5R)-2-(Hydroxymethyl)-5-(4-(trimethylsilyl)but-3-ynyl)tetrahydrofuran-3-ol 
(2-99) 
A flask with Co(nmp)2 (12.5 mg, 0.02 mmol) was evacuated and placed under an O2 
atmosphere and added a solution of diol 2-100 (39.3 mg, 0.17 mmol) in iPrOH (2 mL). 
tBuOOH (5.74 M in isooctane, 4.0 μL, 0.02 mmol) was added and stirred at 55 °C 
overnight. After stirring overnight the reaction had not gone to completion so added 
additional Co(nmp)2 (5.6 mg, 0.01 mmol) and stirred until diol was consumed (21 h from 
initial addition of Co(nmp)2). The volatiles were removed (rotary evaporator followed by 
high vacuum), the residue was dissolved in EtOAc (5 mL), filtered through silica gel on a 
pad of Celite and washed with additional EtOAc (10 mL). The mixture was concentrated 
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to dryness to afford the title compound as a light yellow oil (38.5 mg, 93%). Rf 0.18 (1:1 
hexanes/EtOAc); 
1
H NMR (CDCl3, 600 MHz) δ 4.52 (br s, 1H), 4.35 (br s, 1H), 3.93 (br 
s, 2H), 3.14 (br s, 1H), 2.36 - 2.31 (m, 3H), 2.12 (dd, J = 13.5, 5.9 Hz, 1H), 1.80 - 1.74 
(m, 2H), 1.73 - 1.67 (m, 2H), 0.13 (s, 9H); 
13
C NMR (CDCl3, 101 MHz) δ 106.6, 84.7, 
80.2, 77.1, 74.3, 61.8, 41.9, 34.8, 16.7, 0.1. 
 
 
Methyl 2-((tert-butyldimethylsilyloxy)methyl)acrylate (2-126) 
A solution of alcohol 2-125 (3.55 g, 30 mmol) in CH2Cl2 (60 mL) at 0 °C was added 
imidazole (3.12 g, 45 mmol) and stirred for 15 min. TBSCl (6.93 g, 45 mmol) was added, 
stirred for 30 min at RT, quenched with the addition of a half saturated solution of 
Na2CO3 (aq) and extracted with CH2Cl2 (3 x 20 mL). The combined organic extracts 
were washed with brine, dried over MgSO4, filtered through a pad of Celite and 
concentrated under reduced pressure. The crude reaction mixture was purified by flash 
column chromatography to afford the title compound as a clear colorless oil (6.94 g, 
98%). Rf  0.74 (7:3 hexanes/EtOAc); 
1
H NMR (CDCl3, 600 MHz) δ 6.25 (dt, J = 1.8 Hz, 
1H); 5.91 (dt, J = 1.8 Hz, 1H), 4.36 (dd, J = 2.4 Hz, 2H), 3.75 (s, 3H), 0.91 (s, 9H), 0.08 
(s, 6H); 
13
C NMR (CDCl3, 150 MHz) δ 166.4, 139.6, 123.9, 61.5, 51.6, 25.9, 18.3, -5.4; 
HRMS [m/z+H
+
] 231.1412 (calcd for C11H22O3Si, 230.1338). 
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2-((tert-Butyldimethylsilyloxy)methyl)prop-2-en-1-ol (2-127) 
A solution of ester 2-126 (4.61 g, 20 mmol) in THF (40 mL) at -78 °C was added DIBAL 
(1.0 M in hexane, 50 mL, 50 mmol) and stirred at 0 °C for 1 h. The reaction mixture was 
poured into a half saturated solution of Rochelle’s salt (aq), vigorously stirred for 1 h and 
extracted with Et2O (3 x 15 mL). The combined organic extracts were washed with brine, 
dried over MgSO4, filtered through a pad of Celite and concentrated under reduced 
pressure. The crude reaction mixture was purified by flash column chromatography to 
afford the title compound as a clear colorless oil (3.45 g, 85%). Rf  0.21 (9:1 
hexanes:EtOAc); 
1
H NMR (CDCl3, 400 MHz) δ 5.08 (d, J = 6.6 Hz, 2H); 4.23 (s, 2H), 
4.16 (d, J = 5.9 Hz, 2H), 0.90 (s, 9H), 0.08 (s, 6H); 
13
C NMR (CDCl3, 101 MHz) δ 147.4, 
111.1, 65.1, 64.7, 25.8, 18.3, -5.4; HRMS [m/z+H
+
] 203.1466 (calcd for C10H22O2Si, 
202.1389). 
 
 
2-((tert-Butyldimethylsilyloxy)methyl)acryaldehyde (2-128) 
The title compound was prepared under the same Swern conditions as with aldehyde 2-
117 to provide a yellow oil (1.86 g, 93%). Rf  0.77 (9:1 hexanes/EtOAc); 
1
H NMR 
(CDCl3, 600 MHz) δ 9.61 (s, 1H), 6.51 (s, 1H), 6.09 (s, 1H), 4.39 (s, 2H), 0.91 (s, 9H), 
0.08 (s, 6H); 
13
C NMR (CDCl3, 101 MHz) δ 193.6, 149.5, 132.8, 59.6, 25.8, 18.3, -5.5; 
HRMS m/z 200.1299 (calcd for C10H20O2Si, 200.1233). 
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Ethyl 4-((tert-butyldimethylsilyloxy)methyl)-3-hydroxypent-4-enoate (2-129) 
A solution of iPr2NH (1.44 mL, 10.3 mmol) in THF (16 mL) at 0 °C was added BuLi 
(2.36 M in hexanes, 3.80 mL, 9 mmol) and stirred for 15 min. The mixture was cooled to 
-60 °C and  freshly distilled EtOAc (885 μL, 9 mmol) was added dropwise and stirred for 
30 min. A solution of aldehyde 2-120 in THF (2 mL) was added dropwise, warmed to -40 
°C, stirred for 45 min, quenched by the addition of a half saturated solution of NH4Cl 
(aq), allowed to warm to RT and extracted with EtOAc (3 x 10 mL). The combined 
organic extracts were washed with brine, filtered through a pad of Celite and 
concentrated under reduced pressure. The crude reaction mixture was purified by flash 
column chromatography to afford the title compound as a yellow oil (2.01 g, 84 %). Rf  
0.26 (9:1 hexanes/EtOAc); 
1
H NMR (CDCl3, 600 MHz) δ 5.13 (s, 2H), 4.63-4.60 (m, 
1H), 4.25 (dd, J = 13.5 Hz, 2H), 4.16 (q, J = 7.0 Hz, 2H), 3.24 (d, 4.7 Hz, 1H), 2.68-2.61 
(m, 2H), 1.26 (t, J = 7.0 Hz, 3H), 0.90 (s, 9H), 0.08 (s, 6H); 
13
C NMR (CDCl3, 101, 
MHz) δ 172.3, 148.1, 111.3, 69.6, 64.4, 60.7, 40.7, 25.8, 18.3, 14.2, -5.5; HRMS 
[m/z+H
+
] 289.1831 (calcd for C14H28O4Si,
 
288.1757). 
 
 
tert-Butyl-4-((tert-butyldimethylsilyloxy)methyl)-3-hydroxypent-4-eneoate (2-130) 
The title compound was prepared by the same procedure as ethyl ester 2-129 as a clear 
colorless oil (1.12 g, 88%). Rf 0.47 (9:1 hexanes/EtOAc); 
1
H NMR (CDCl3, 600 MHz) δ 
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5.12 (s, 2H), 4.56 - 4.53 (m, 1H), 4.27 - 4.21 (m, 2H), 3.32 (d, J = 4.7 Hz, 1H), 2.60 - 
2.52 (m, 2H), 1.45 (s, 9H), 0.90 (s, 9H), 0.07 (s, 6H); 
13
C NMR (CDCl3, 150 MHz) δ 
171.7, 148.4, 110.9, 81.2, 69.6, 64.3, 41.6, 28.1, 25.8, 18.2, -5.5; HRMS m/z pending 
(calcd for C16H32O4Si 316.2070). 
 
 
tert-Butyl-4-((tert-butyldimethylsilyloxy)methyl)-3-oxopent-4-eneoate (2-132) 
A solution of allylic alcohol 2-130 (151.2 mg, 0.48 mmol), DMSO (170 μL), iPr2NEt 
(590 μL, 3.4 mmol) in CH2Cl2 (5 mL) at 0 °C was added SO3·py (230 mg, 1.44 mmol). 
The reaction was stirred for 4 h at 0 °C and continued at RT overnight. The reaction was 
diluted with CH2Cl2 (5 mL), quenched with a half saturated solution of NaHCO3 (aq) and 
extracted with CH2Cl2 (3 x 5 mL). The combined organic extracts were washed with 
CuSO4 (2 x 5 mL), H2O (2 x 5 mL), brine (2 x 5 mL), dried over MgSO4, filtered through 
a pad of Celite and concentrated under reduced pressure. The crude reaction mixture was 
purified by flash column chromatography to afford the title compound as a yellow oil 
(125 mg, 83%). Rf 0.86 (4:1 hexanes/EtOAc); 
1
H NMR (CDCl3, 600 MHz) δ 6.17 (s, 
1H), 6.09 (s, 1H), 4.37 (s, 2H), 3.63 (s, 2H), 1.44 (s, 9H), 0.91 (s, 9H), 0.07 (s, 6H); 
13
C 
NMR (CDCl3, 150 MHz) δ 193.8, 166.6, 147.2, 124.7, 60.9, 46.9, 28.3, 27.9, 25.8, 18.3, -
5.5. 
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Ethyl 3-(tert-butyldimethylsilyloxy)-4-((tert-butyldimethylsilyloxy)methyl)pent-4-
eneoate (2-134) 
A solution of allylic alcohol 2-129 (870 mg, 3 mmol) in CH2Cl2 (8 mL) cooled to 0 °C 
was added imidazole (310 mg, 4.55 mmol), stirred for 15 min and added TBSCl (687 mg, 
4.55 mmol). After stirring overnight, the reaction had not gone to completion and 
additional imidazole (104 mg, 1.53 mmol) and TBSCl (235 mg, 1.53 mmol) was added 
and stirred. Once complete (by TLC), the reaction mixture was poured into a separatory 
funnel containing H2O (10 mL). The organic layer was washed with H2O, then brine, 
dried over MgSO4, filtered through a pad of Celite and concentrated under reduced 
pressure. The crude reaction mixture was purified by flash column chromatography to 
provide the title compound as a yellow oil (1.17 g, 96%). Rf 0.70 (9:1 hexanes/EtOAc); 
1
H NMR (CDCl3, 600 MHz) δ 5.11 (s, 2H), 4.68 (dd, J = 8.5, 4.4 Hz, 1H), 4.18 (s, 2H), 
4.16-4.06 (m, 2H), 2.56-2.48 (m, 2H), 1.25 (t, J = 7.0 Hz, 3H), 0.90 (s, 9H), 0.85 (s, 9H), 
0.06 (s, 6H), 0.03 (s, 3H), 0.00 (s, 3H); 
13
C NMR (CDCl3, 150 MHz) δ 171.3, 149.9, 
110.3, 71.4, 62.5, 60.4, 43.4, 25.9, 25.7, 18.3, 18.0, 14.2, -4.7, -5.4, -5.5; HRMS 
[m/z+H
+
] 403.2712 (calcd for C20H42O4Si2 402.2622). 
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3-(tert-Butyldimethylsilyloxy)-4-((tert-butyldimethylsilyloxy)methyl)pent-4-eneoic 
acid (2-135) 
A solution of ester 2-129 (200 mg, 0.49 mmol) in EtOH (3 mL) and H2O (1 mL) was 
added LiOH·H2O (64 mg, 1.5 mmol) slowly. After stirring overnight the mixture was 
acidified with 10% HCl (aq) to pH 3. Diluted with EtOAc (5 mL) and H2O (5 mL), 
extracted with EtOAc (3 x 5 mL). The combined organics were washed with brine, dried 
over MgSO4, filtered through a pad of Celite and concentrated under reduced pressure to 
afford a light yellow oil (159 mg, 94%) which was used without further purification. Rf 
0.44 (4:1 hexanes/EtOAc); 
1
H NMR (CDCl3, 600 MHz) δ 5.17 -  5.11 (m, 2H), 4.70 - 
4.66 (m, 1H), 4.24 - 4.13 (m, 2H), 2.69 - 2.62 (m, 2H), 0.90 (s, 9H), 0.89 (s, 9H), 0.09 - 
0.05 (m, 12H); 
13
C NMR (CDCl3, 150 MHz) δ 176.3, 149.1, 111.3, 70.9, 62.8, 42.9, 25.9, 
25.7, 18.3, 18.0, -4.8, -5.4. 
 
 
4-(4-Methoxybenzyloxy)butyl 3-(tert-butyldimethylsilyloxy)-4-((tert-
butyldimethylsilyloxy)methyl)pent-4-eneoate (2-171) 
To a stirred solution of acid XX (192.3 mg, 0.51 mmol) in THF (2.5 mL) was added PPh3 
(334 mg, 1.27 mmol) followed by alcohol XX (168 mg, 0.79 mmol). DIAD (210 μL) was 
added dropwise over 2 mins. After 4.5 h a half-saturated solution of NaHCO3 (aq) (10 
mL) and Et2O (10 mL) and the aqueous layer was extracted with Et2O (3 x 10 mL). The 
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combined organics were dried (MgSO4), filtered through a plug of Celite and 
concentrated under reduced pressure. The crude residue was purified by column 
chromatography to afford the title compound (109 mg, 38%) as a yellow oil. Rf 0.38 
(20:1 hexanes/EtOAc); 
1
H NMR (CDCl3, 600 MHz) δ 7.24 (d, J = 8.2 Hz, 2H), 6.86 (d, J 
= 8.8 Hz, 2H), 5.10 (s, 2H), 4.67 (dd, J = 8.5, 4.4 Hz, 1H), 4.42 (s, 2H), 4.18 (s, 2H), 3.79 
(s, 3H), 3.45 (d, J= 6.2 Hz, 2H), 2.56 - 2.48 (m, 2H), 1.73 - 1.69 (m, 2H), 1.67 - 1.64 (m, 
2H), 0.90 (s, 9H), 0.85 (s, 9H), 0.06 (s, 6H), 0.02 (s, 3H), 0.00 (3H); 
13
C NMR (CDCl3, 
150 MHz) δ 171.3, 159.1, 149.8, 130.6, 129.2, 113. 8, 110.3, 72.6, 71.4, 69.4, 64.3, 62.5, 
55.2, 43.3, 26.7, 25.9, 25.5, 18.3, 18.0, -4.7, -5.3, -5.4; HRMS [m/z+H
+
] 567.3523 (calcd 
for C30H54O6Si2 566.3459). 
 
 
4-Hydroxybutyl 3-(tert-butyldimethylsilyloxy)-4-((tert-
butyldimethylsilyloxy)methyl)pent-4-enoate (2-172) 
To a stirred solution of ester XX (118 mg, 0.21 mmol) in CH2Cl2 (2.2 mL) and H2O 
(0.125 mL) was added DDQ (71.8 mg, 0.32 mmol). After stirred for 3 h a half-saturated 
solution of NaHCO3 (aq) was added and extracted with CH2Cl2 (3 x 10 mL). The 
combined organics were washed with saturated NaHCO3 (aq) then brine, dried (MgSO4), 
filtered through a plug of Celite and concentrated under reduced pressure to afford the 
title compound (82.8 mg, 88%) as a clear oil. Rf 0.17 (9:1 hexanes/EtOAc); 
1
H NMR 
(CDCl3, 400 MHz) δ 5.11 (s, 2H), 4.67 (dd, J = 8.2, 4.7 Hz, 1H), 4.19 (s, 2H), 4.12 - 4.05 
(m, 2H), 3.69 - 3.64 (m, 2H), 2.58 - 2.48 (m, 2H), 1.75 - 1.68 (m, 2H), 1.65 - 1.59 (m, 
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2H), 0.90 (s, 9H), 0.85 (s, 9H), 0.06 (s, 6H), 0.02 (s, 3H), 0.00 (s, 3H); 
13
C NMR (CDCl3, 
101 MHz) δ 171.4, 149.7, 110.4, 71.4, 64.2, 62.5, 43.3, 29.1, 25.9, 25.7, 25.0, 18.3, 18.0, 
-4.8, -5.4. 
 
 
4-(3-tertButyldimethylsilyloxy)-4-((tert-butyldimethylsilyloxy)methyl)pent-4-
enoyloxy)butanoic acid (2-173) 
To a stirred solution of alcohol (82 mg, 0.18 mmol) in MeCN (0.8 mL) and H2O (0.8 mL) 
was added TEMPO (37 mg, 0.24 mmol) and PhI(OAc)2 (204 mg, 0.63 mmol). After 
stirring for 4 h the mixture was diluted with EtOAc (3 mL) and H2O (3 mL) and extracted 
with EtOAc (3 x 10 mL). The combined organic extracts were dried (MgSO4), filtered 
through a plug of Celite and concentrated under reduced pressure to afford the title 
compound (77 mg, 93%) as a light yellow oil. Rf 0.16 (4:1 hexanes/EtOAc); 
1
H NMR 
(CDCl3, 600 MHz) δ 5.11 (s, 2H), 4.68 - 4.66 (m, 1H), 4.19 (s, 2H), 4.12 - 4.08 (m, 2H), 
2.45 (t, J = 7.0 Hz, 2H), 1.98 - 1.93 (m, 2H), 0.90 (s, 9H), 0.84 (s, 9H), 0.06 (s, 6H), 0.02 
(s, 3H), 0.00 (s, 3H); 
13
C NMR (CDCl3, 101 MHz) δ 178.5, 171.2, 149.6, 110.5, 71.3, 
63.3, 62.6, 43.1, 30.5, 25.9, 23.7, 18.3, 18.0, -4.8, -5.4. 
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Chapter 3 - Conclusions 
 Two chapters have been discussed in this thesis. A common theme which ties the 
two chapters together is the synthetic challenges associated with organic chemistry. 
Heterocyclic compounds have been synthesized both bearing oxygen atoms contained 
within ring. The development of methodology in a synthetic chemistry lab can give a 
great learning experience while testing a students’ ability to overcome these challenges 
and show interesting and unexpected reactivity patterns of simple starting material. 
 The first chapter in this thesis attempted to use a common donor-acceptor 
cyclobutanediester to generate highly functionalized ring systems. A collaborative work 
with two other graduate students where the authors’ primary contribution was the 
optimization of the reaction of aldehydes with a furan-substituted cyclobutanediester 
gave moderate to good yields of a fascinating fused acetal product exclusively as a cis 
diastereomer.  
 The second portion of the first chapter was an independent work applying all-
carbon reaction partners with a furan-substituted cyclobutanediester in the presence of a 
Lewis acid. Although the yields of the reaction product were moderate at best, the 
reactivity and product was highly unexpected and required a significant amount of 
structure elucidation. When terminal alkynes were employed in the reaction, an 
addition/rearrangement occurred which gave rise to a dihydrooxepine. Under the 
developed reaction conditions a single cyclobutanediester was able to undergo the 
reaction without decomposing into unidentified compounds. Two plausible mechanisms 
were proposed where the product was generated through a C-O bond migration or by a 
ring opening of a highly strained bicyclic oxonium ion. A C-O bond migration is more 
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likely as the highly strained intermediate generated in the oxonium ion intermediate 
would be very hard to form. A second dihydrooxepine was proposed, and even though a 
C-C bond migration would be a feasible means to open the ring, the absence of 
correlations in the HMBC of the product did not support this product. More interesting 
was the generation of the desired [4+2] when a sterically bulky silyloxy substituted 
phenylacetylene was used in the reaction, although low yield (24%) was obtained, the 
presence of the additional steric bulk was presumed to limit the bond migration observed 
in the other cases leading to the cyclohexene product.  
 The second chapter presented a collaborative work towards the total synthesis of 
biselide A between the author and a previous graduate student, Barbora Morra. A 
repetition of Barbora Morra’s work was undertaken to access a functionalized THF-diol 
which was not able to be elaborated any further. The author’s contribution to this project 
was the development of an appropriate length tether for the acid portion of the molecule 
which had been planned out to undergo ring closing metathesis with a THF-diol that had 
been previously synthesized. To this end, the incorporation of a five atom tethered acid 
portion onto an acid portion, whose synthesis had been worked out previously and was 
repeat, was accomplished to give the acid functionality which was to be connected to the 
secondary alcohol on the THF. The total synthesis of biselide A was not accomplished, 
however the two key compounds to form the macrocycle of the natural product have been 
synthesized.  
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APPENDIX II - NMR Data for Reactions of DA-cyclobutanes (Chapter 1) 
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Diethyl 2-oxabicyclo[3.2.0]heptane-7,7-dicarboxylate (1-37) 
 
1
H NMR (CDCl3, 600 MHz) 
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Diethyl 2-oxabicyclo[3.2.0]heptanes-7,7-dicarboxylate (1-37) 
 
13
C NMR (CDCl3, 101 MHz) 
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(6R,7aR)-Diethyl 6-phenyltetrahydro-2H-furo[2,3-b]pyran-5,5(3H)-dicarboxylate  
(1-38a) 
 
1
H NMR (CDCl3, 600 MHz) 
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(6R,7aR)-Diethyl 6-phenyltetrahydro-2H-furo[2,3-b]pyran-5,5(3H)-dicarboxylate  
(1-38a) 
 
13
C NMR (CDCl3, 101 MHz) 
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(3aR*,6R*,7aR*)-Diethyl 6-(4-cyanophenyl)-tetrahydro-2H-furo[2,3-b]pyran-
5,5(3H)-dicarboxylate (1-38d) 
 
1
H NMR (CDCl3, 400 MHz) 
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(3aR*,6R*,7aR*)-Diethyl 6-(4-cyanophenyl)-tetrahydro-2H-furo[2,3-b]pyran-
5,5(3H)-dicarboxylate (1-38d) 
 
13
C NMR (CDCl3, 101 MHz) 
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(3aR*,6R*,7aR*)-Diethyl 6-(naphthalen-1-yl)-tetrahydro-2H-furo[2,3-b]pyran-
5,5(3H)-dicarboxylate (1-38f) 
 
1
H NMR (CDCl3, 400 MHz) 
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(3aR*,6R*,7aR*)-Diethyl 6-(naphthalen-1-yl)-tetrahydro-2H-furo[2,3-b]pyran-
5,5(3H)-dicarboxylate (1-38f) 
 
13
C NMR (CDCl3, 101 MHz) 
 
 
 
146 
 
 
(3aR*,6R*,7aR*)-Diethyl 6-(furan-2-yl)-tetrahydro-2H-furo[2,3-b]pyran-5,5(3H)-
dicarboxylate (1-38j) 
 
1
H NMR (CDCl3, 400 MHz) 
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(3aR*,6R*,7aR*)-Diethyl 6-(furan-2-yl)-tetrahydro-2H-furo[2,3-b]pyran-5,5(3H)-
dicarboxylate (1-38j) 
 
13
C NMR (CDCl3, 101 MHz) 
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(3aR*,6R*,7aR*)-Diethyl 6-(1-tosyl-1H-indol-1-yl)-tetrahydro-2H-furo[2,3-b]pyran-
5,5(3H)-dicarboxylate (1-38l) 
 
1
H NMR (CDCl3, 600 MHz) 
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(3aR*,6R*,7aR*)-Diethyl 6-(1-tosyl-1H-indol-1-yl)-tetrahydro-2H-furo[2,3-b]pyran-
5,5(3H)-dicarboxylate (1-38l) 
 
13
C NMR (CDCl3, 150 MHz) 
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(3aR*,6R*,7aR*)-Diethyl 6-methyl-tetrahydro-2H-furo[2,3-b]pyran-5,5(3H)-
dicarboxylate (1-38p) 
 
1
H NMR (CDCl3, 400 MHz) 
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(3aR*,6R*,7aR*)-Diethyl 6-methyl-tetrahydro-2H-furo[2,3-b]pyran-5,5(3H)-
dicarboxylate (1-38p) 
 
13
C NMR (CDCl3, 101 MHz) 
 
 
 
152 
 
 
Diethyl 6-(4-(tert-butyldimethylsiloxy)phenyl)-2,3,3a,4-tetrahydrobenzofuran-
5,5(7aH)-dicarboxylate (1-57) 
 
1
H NMR (CDCl3, 600 MHz) 
 
 
 
153 
 
 
Diethyl 6-(4-(tert-butyldimethylsiloxy)phenyl)-2,3,3a,4-tetrahydrobenzofuran-
5,5(7aH)-dicarboxylate (1-57) 
 
13
C NMR (CDCl3, 101 MHz) 
 
 
 
154 
 
 
Diethyl 2-(((4Z,6Z)-7-phenyl-2,3-dihydrooxepin-4-yl)methyl) malonate (1-59a) 
 
1
H NMR (CDCl3, 600 MHz) 
 
 
 
155 
 
 
Diethyl 2-(((4Z,6Z)-7-phenyl-2,3-dihydrooxepin-4-yl)methyl) malonate (1-59a) 
 
13
C NMR (CDCl3, 101 MHz) 
 
 
 
156 
 
 
Diethyl 2-(((4Z,6Z)-7-p-tolyl-2,3-dihydrooxepin-4-yl)methyl) malonate (1-59b) 
 
1
H NMR (CDCl3, 400 MHz) 
 
 
 
157 
 
 
Diethyl 2-(((4Z,6Z)-7-p-tolyl-2,3-dihydrooxepin-4-yl)methyl) malonate (1-59b) 
 
13
C NMR (CDCl3, 101 MHz) 
 
 
 
158 
 
 
Diethyl 2-(((4Z,6Z)-7-(4-bromophenyl)-2,3-dihydrooxepin-4-yl)methyl) malonate  
(1-59c) 
 
1
H NMR (CDCl3, 600 MHz) 
 
 
159 
 
 
Diethyl 2-(((4Z,6Z)-7-(4-bromophenyl)-2,3-dihydrooxepin-4-yl)methyl) malonate  
(1-59c) 
 
13
C NMR (CDCl3, 150 MHz) 
 
 
160 
 
 
Diethyl 2-(((4Z,6Z)-7-(4-iodophenyl)-2,3-dihydrooxepin-4-yl)methyl) malonate  
(1-59d) 
 
1
H NMR (CDCl3, 600 MHz) 
 
 
 
161 
 
 
Diethyl 2-(((4Z,6Z)-7-(4-iodophenyl)-2,3-dihydrooxepin-4-yl)methyl) malonate  
(1-59d) 
 
13
C NMR (CDCl3, 150 MHz) 
 
 
 
162 
 
 
Diethyl 2-(((4Z,6Z)-7-(napthalen-1-yl)-2,3-dihydrooxepin-4-yl)methyl) malonate  
(1-59e) 
 
1
H NMR (CDCl3, 400 MHz) 
 
 
 
163 
 
 
Diethyl 2-(((4Z,6Z)-7-(napthalen-1-yl)-2,3-dihydrooxepin-4-yl)methyl) malonate  
(1-59e) 
 
13
C NMR (CDCl3, 101 MHz) 
 
 
 
164 
 
 
Diethyl 2-(((4Z,6Z)-7-(4-acetoxyphenyl)-2,3-dihydrooxepin-4-yl)methyl) malonate  
(1-59f) 
 
1
H NMR (CDCl3, 600 MHz) 
 
 
 
165 
 
 
Diethyl 2-(((4Z,6Z)-7-(4-acetoxyphenyl)-2,3-dihydrooxepin-4-yl)methyl) malonate  
(1-59f) 
 
13
C NMR (CDCl3, 150 MHz) 
 
 
 
166 
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Ethyl 2-(4-methylpiperazin-1-yl)-2-oxoacetate (2-130) 
 
1
H NMR (CDCl3, 400 MHz) 
 
 
 
168 
 
 
 
Ethyl 2-(4-methylpiperazin-1-yl)-2-oxoacetate (2-130) 
 
13
C NMR (CDCl3, 101 MHz) 
 
 
169 
 
 
(Z)-2-Hydroxy-5,5-dimethyl-1-(4-methylpiperazin-1-yl)hex-2-ene-1,4-dione (2-131) 
 
1
H NMR (CDCl3, 400 MHz) 
 
 
 
 
170 
 
 
(Z)-2-Hydroxy-5,5-dimethyl-1-(4-methylpiperazin-1-yl)hex-2-ene-1,4-dione (2-131) 
 
13
C NMR (CDCl3, 101 MHz) 
 
 
 
171 
 
 
(S)-4-Benzyl-3-(2-chloroacetyl)oxazolidin-2-one (2-142) 
 
1
H NMR (CDCl3, 600 MHz) 
 
 
 
172 
 
 
(S)-4-Benzyl-3-(2-chloroacetyl)oxazolidin-2-one (2-142) 
 
13
C NMR (CDCl3, 101 MHz) 
 
 
 
173 
 
 
(S)-4-Benzyl-3-((2S,3R)-2-chloro-3-hydroxy-7-(trimethylsilyl)hept-6-
ynoyl)oxazolidin-2-one (2-145) 
 
1
H NMR (CDCl3, 600 MHz) 
 
 
 
174 
 
 
(S)-4-Benzyl-3-((2S,3R)-2-chloro-3-hydroxy-7-(trimethylsilyl)hept-6-
ynoyl)oxazolidin-2-one (2-145) 
 
13
C NMR (CDCl3, 150 MHz) 
 
 
 
175 
 
 
(S)-4-Benzyl-3-((R)-3-hydroxy-7-(trimethylsilyl)hept-6-ynoyl)oxazolidin-2-one  
(2-146) 
 
1
H NMR (CDCl3, 600 MHz) 
 
 
 
176 
 
 
(S)-4-Benzyl-3-((R)-3-hydroxy-7-(trimethylsilyl)hept-6-ynoyl)oxazolidin-2-one  
(2-146) 
 
13
C NMR (CDCl3, 150 MHz) 
 
 
 
177 
 
 
(R)-3-Hydroxy-N-methoxy-N-methyl-7-(trimethylsilyl)hept-6-ynamide (2-147) 
 
1
H NMR (CDCl3, 600 MHz) 
 
 
 
178 
 
 
(R)-3-Hydroxy-N-methoxy-N-methyl-7-(trimethylsilyl)hept-6-ynamide (2-147) 
 
13
C NMR (CDCl3, 101 MHz) 
 
 
 
179 
 
 
(R)-5-Hydroxy-9-(trimethylsilyl)non-1-en-8-yn-3-one (2-148) 
 
1
H NMR (CDCl3, 600 MHz) 
 
 
 
 
180 
 
 
(R)-5-Hydroxy-9-(trimethylsilyl)non-1-en-8-yn-3-one (2-148) 
 
13
C NMR (CDCl3, 150 MHz) 
 
 
 
181 
 
 
(3R,5R)-9-(Trimethylsilyl)non-1-en-8-yne-3,5-diol (2-127) 
 
1
H NMR (CDCl3, 600 MHz) 
 
 
 
182 
 
 
(3R,5R)-9-(Trimethylsilyl)non-1-en-8-yne-3,5-diol (2-127) 
 
13
C NMR (CDCl3, 150 MHz) 
 
 
 
183 
 
 
(2R,3R,5R)-2-(Hydroxymethyl)-5-(4-(trimethylsilyl)but-3-ynyl)tetrahydrofuran-3-ol 
(2-126) 
 
1
H NMR (CDCl3, 600 MHz) 
 
 
 
184 
 
 
(2R,3R,5R)-2-(Hydroxymethyl)-5-(4-(trimethylsilyl)but-3-ynyl)tetrahydrofuran-3-ol 
(2-126) 
 
13
C NMR (CDCl3, 101 MHz) 
 
 
 
185 
 
 
Methyl 2-((tert-butyldimethylsilyloxy)methyl)acrylate (2-158) 
 
1
H NMR (CDCl3, 600 MHz) 
 
 
 
186 
 
 
Methyl 2-((tert-butyldimethylsilyloxy)methyl)acrylate (2-158) 
 
13
C NMR (CDCl3, 150 MHz) 
 
 
 
187 
 
 
2-((tert-Butyldimethylsilyloxy)methyl)prop-2-en-1-ol (2-159) 
 
1
H NMR (CDCl3, 400 MHz) 
 
 
 
188 
 
 
2-((tert-Butyldimethylsilyloxy)methyl)prop-2-en-1-ol (2-159) 
 
13
C NMR (CDCl3, 101 MHz) 
 
 
 
189 
 
 
2-((tert-Butyldimethylsilyloxy)methyl)acryaldehyde (2-160) 
 
1
H NMR (CDCl3, 600 MHz) 
 
 
 
 
190 
 
 
2-((tert-Butyldimethylsilyloxy)methyl)acryaldehyde (2-160) 
 
13
C NMR (CDCl3, 101 MHz) 
 
 
 
191 
 
 
Ethyl 4-((tert-butyldimethylsilyloxy)methyl)-3-hydroxypent-4-enoate (2-161) 
 
1
H NMR (CDCl3, 600 MHz) 
 
 
 
192 
 
 
Ethyl 4-((tert-butyldimethylsilyloxy)methyl)-3-hydroxypent-4-enoate (2-161) 
 
13
C NMR (CDCl3, 101 MHz) 
 
 
 
193 
 
 
tert-Butyl-4-((tert-butyldimethylsilyloxy)methyl)-3-hydroxypent-4-eneoate (2-162) 
 
1
H NMR (CDCl3, 600 MHz) 
 
 
 
 
194 
 
 
tert-Butyl-4-((tert-butyldimethylsilyloxy)methyl)-3-hydroxypent-4-eneoate (2-162) 
 
13
C NMR (CDCl3, 150 MHz) 
 
 
 
 
195 
 
 
tert-Butyl-4-((tert-butyldimethylsilyloxy)methyl)-3-oxopent-4-eneoate (2-165) 
 
1
H NMR (CDCl3, 600 MHz) 
 
 
 
196 
 
 
tert-Butyl-4-((tert-butyldimethylsilyloxy)methyl)-3-oxopent-4-eneoate (2-165) 
 
13
C NMR (CDCl3, 150 MHz) 
 
 
 
197 
 
 
Ethyl 3-(tert-butyldimethylsilyloxy)-4-((tert-butyldimethylsilyloxy)methyl)pent-4-
eneoate (2-166) 
 
1
H NMR (CDCl3, 600 MHz) 
 
 
 
198 
 
 
Ethyl 3-(tert-butyldimethylsilyloxy)-4-((tert-butyldimethylsilyloxy)methyl)pent-4-
eneoate (2-166) 
 
13
C NMR (CDCl3, 150 MHz) 
 
 
 
 
199 
 
 
3-(tert-Butyldimethylsilyloxy)-4-((tert-butyldimethylsilyloxy)methyl)pent-4-eneoic 
acid (2-167) 
 
1
H NMR (CDCl3, 600 MHz) 
 
 
 
200 
 
 
3-(tert-Butyldimethylsilyloxy)-4-((tert-butyldimethylsilyloxy)methyl)pent-4-eneoic 
acid (2-167) 
 
13
C NMR (CDCl3, 150 MHz) 
 
  
 
201 
 
 
4-(4-Methoxybenzyloxy)butyl 3-(tert-butyldimethylsilyloxy)-4-((tert-
butyldimethylsilyloxy)methyl)pent-4-eneoate (2-171) 
 
1
H NMR (CDCl3, 600 MHz) 
 
 
 
202 
 
 
4-(4-Methoxybenzyloxy)butyl 3-(tert-butyldimethylsilyloxy)-4-((tert-
butyldimethylsilyloxy)methyl)pent-4-eneoate (2-171) 
 
13
C NMR (CDCl3, 150 MHz) 
 
 
 
203 
 
 
4-Hydroxybutyl 3-(tert-butyldimethylsilyloxy)-4-((tert-
butyldimethylsilyloxy)methyl)pent-4-enoate (2-172) 
 
1
H NMR (CDCl3, 600 MHz) 
 
 
 
204 
 
 
4-Hydroxybutyl 3-(tert-butyldimethylsilyloxy)-4-((tert-
butyldimethylsilyloxy)methyl)pent-4-enoate (2-172) 
 
13
C NMR (CDCl3, 101 MHz) 
 
 
 
205 
 
 
4-(3-tertButyldimethylsilyloxy)-4-((tert-butyldimethylsilyloxy)methyl)pent-4-
enoyloxy)butanoic acid (2-173) 
 
1
H NMR (CDCl3, 600 MHz) 
 
 
 
206 
 
 
4-(3-tertButyldimethylsilyloxy)-4-((tert-butyldimethylsilyloxy)methyl)pent-4-
enoyloxy)butanoic acid (2-173) 
 
13
C NMR (CDCl3, 101 MHz) 
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